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The main aim of the modern scientific interdisciplinary field known as Tissue 
Engineering is to design artificial biocompatible materials to substitute irreversibly 
damaged tissue of an organs. Its strategy focuses on the creation of hybrid artificial 
organs to improve the quality of life for many patients. Tissue engineering is finding wide 
application in liver regeneration. The need to develop new artificial substitutes to use in 
liver tissue engineering is due to its crucial role in body’s metabolism. The number of 
functions in the body, including glycogen storage, decomposition of red blood cells, 
plasma protein synthesis, and detoxification highlight the importance to develop new 
methodologies that will be able to restore the complete functionality of theorgan damaged 
by traumatic and pathologic events. Actually, the common procedures for liver failures 
still remain organ transplantation. However, as demand for donor organs continues to 
increase beyond their availability, the need for alternative therapies is clear. Several 
approaches have been proposed including extracorporeal devices. The artificial liver 
systems represent a temporary bridge to support a patient awaiting for a new organ but the 
number of hepatocytes required is higher than the real availability of cells. In this respect 
the need for more effective solutions appear extremely important. The development of 
biological substitutes based on living cells grown and supported onto polymer matrices 
seems to be a valid solution. 
In the framework of a long-standing activity ongoing at the Bioactive Polymeric Material 
group at the Department of Chemistry and Industrial Chemistry of the University of Pisa, 
the present work was aimed both at the development of polymeric scaffolds based on 
naturally derived materials for cell culturing and particles containing cells and/or tissue 
specific growth factors to be used in regenerative medicine of liver. In the present PhD 
thesis the potential of a new type of alginate, namely Ulvan derived from marine 
renewable resource, to be used in biomedical applications as alternative material to 
commercial alginate was submitted to investigation. Four different batches of Ulvan with 
different physical aspect (flakes, powder and laminae), were investigated. The use of 
natural polymers, or biopolymers, as structural material is known since a while. 
Polysaccharides are known to show a variability and versatility, associated with their 
complex structures, not found in other classes of polymers and their gelling ability are 
increasingly being used in biotechnological applications. The improvement of the stability 
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of soft gels produced by these polysaccharides represented the first research goal. By 
introduction of physical and chemical crosslinking agents in scaffolds formulation the 
mechanical stability of these polysaccharides were successfully improved and scaffolds 
resistant to dissolution in physiological conditions were obtained. The morphological 
characterization of the prepared constructs, as performed by Scanning Electron 
Microscopy (SEM), revealed the interconnected porous structure with pores size (100 
µm) favourable to cell attachment and proliferation. A careful in vitro investigation of 
Ulvan cytotoxicity was carried out by using neutral red uptake assay aimed to assess the 
viability of cells exposed to different polymer concentrations. Quantitative results clearly 
showed a good cytocompatibility of the investigated Ulvan samples also at high 
concentration such as 10 mg/ml. These results were further confirmed by morphological 
investigation performed by using optical microscopy.  
The prepared systems were finally submitted to biological evaluation by seeding a 
hepatoblastoma cell line (HepG2). The gained results revealed not only the mechanical 
stability of the prepared constructs under physiological conditions but also their capability 
to sustain cell adhesion and proliferation. The seeded cells indeed formed large 
aggregates, namely spheroids, maintaining their morphology and viability in the three 
dimensional structure for all the investigation period. 
Tissue engineering of cell loaded beads represent another emerging cellular therapy for 
liver diseases. The encapsulation of cells into microcapsules has been widely explored by 
several reasearchers to overcome the problem of immune rejection or allogenic tissue. 
The ionotropic gelation technique based on the gelation using divalent cation was 
exploited for the preparation of HepG2 loaded beads. Cells were successfully 
encapsulated in spherical beads with smooth surface and 700 ±328 µm in size. 
Quantitative evaluation of cell proliferation performed by mean of WST-1 tetrazolium 
salt assay revealed that encapsulated cells in alginate beads display a proliferation 
comparable to the monolayer culture. Cell morphology was assessed by microscopy after 
treatment with Neutral Red.  
With today’s interest in novel renewable chemicals and polymers, the underexploited 
marine green algae belonging to Ulva species stimulated our interest as source of 
polysaccharides with innovative structure and functional properties. Their relatively low 
cost could also promote their use in environmental and pharmaceutical applications. The 
chemical structure and type of gelling mechanism of these natural polymers may strongly 
ABSTRACT 
 3 
affect the final properties of the polymeric network and therefore their final application. 
For all these reasons the structure of Ulvan was deeply investigated. 
Chemical-physical characterization of Ulvan was carried out in order to determine the 
molecular weight and the content of neutral sugars, uronic acids and proteins. Molecular 
weight evaluated by means of Size Exclusion Chromatography (SEC) indicated an Mw 
value in the range of 50-60 kDa. The content of neutral sugars determined by gas liquid 
chromatography (GLC) as referred to 2-deoxy-D-galactose commercial standard, 
displayed clear abundance of rhamnose with respect to the other constituent sugars. 
Uronic acid content in Ulvan was assessed using a colorimetric assay based on 3-
hydroxybipheny and glucuronic acid as reference standard Contents of Uronic acid in the 
range of 10% were detected and the performed analyses confirmed the heterogeneous 
structure of the Ulvan under investigation. All obtained results on Ulvan composition 
combined with the results obtained from Ulvan based scaffolds preparation strongly 
suggest the suitability of this new type of alginic materials for biomedical applications. 
Further investigation will be aimed at setting up an appropriate technique for Ulvan based 
beads preparation and the viability evaluation of encapsulated cells. 
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1. INTRODUCTION 
1.1 BIOMATERIALS 
In the last decades biomaterial science has experienced an enormous development, due to 
its peculiar connections with other scientific, medical, and engineering disciplines, 
including molecular and cell biology, human physiology, and material science. The 
continuous flow of knowledge among these fields, and the constant demand for new 
supplies and solutions have driven the biomaterial science to be one of the most 
promising areas of scientific and technological interest. 
 
1.1.1. Definitions and Classifications 
Biomaterial science is by its very nature a rather complex area in continuous evolution. 
Accordingly, it is not an easy task to formulate an exact and unique definition to cover the 
entire concept of biomaterials [Barbucci 1994]. Therefore, it is wise to mention the two 
most widely accepted definitions: 
o “A biomaterial is a nonviable material used in a medical device, intended to interact 
with biological systems” [Williams 1987]. 
o “A biomaterial is a material intended to interface with biological systems to evaluate, 
treat, augment or replace any tissue, organ or function of the body” [European 
Society of Biomaterials, Consensus Conference, Chester, UK, 1991]. 
Many requirements have to be satisfied in the design of biomaterials. In particular, deep 
investigation of the chemical and of the biological characteristics of the environment in 
which the material is expected to perform its action is of utmost importance. Indeed, this 
knowledge may lead to better understanding of the main factors that determine the final 
performances of materials, therefore allowing for the optimization of their design. In most 
cases, the functionality of biomaterials is satisfied through the various mechanical and 
chemical characteristics of currently available materials. Nevertheless, these products 
must retain their functions in an aggressive environment, effectively and safely over the 
desired time, without irritation of the surrounding tissue by either mechanical action or 
possible degradation products. This is ensured only when the material is biocompatible 
(§ 1.1.2). 
According to a general classification, the following groups can be discerned as based on 
the chemical nature of biomaterials [Barbucci 1994]: 
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o Biologically derived materials include naturally occurring proteins (collagen, elastin, 
gelatin), polysaccharides (hyaluronic acid, chitosan, dextran, cellulose), and proteins 
produced with biotechnological techniques (genetic engineering), as well as entire 
cells and natural tissues amongst others. They are often used in combination with 
other synthetic biomaterials, especially in dermatology. 
o Synthetic polymers can be employed in a wide range of applications, of either 
intracorporeal or extracorporeal type. The most common uses include short–term 
devices (sutures, adhesives, artificial tendons, contact lenses), long–term cardiac 
valves, complex systems aimed at substituting the function of body organs (such as 
artificial kidney, heart, pancreas), catheters, filters for hemodialysis, orthopaedic 
material, and drug delivery devices. 
o Metals are mainly used in orthopaedic and dental implants, and in the production of 
pacemakers and heart valves. The most commonly used metals are stainless steel, 
cobalt–based alloys, titanium and its alloys. 
o Composites can be manufactured by the combination of polymers, ceramics, and 
metals. Composites currently used in biomaterial applications include bone particle– 
or carbon fiber–reinforced methyl methacrylate bone cement and ultra–high–
molecular–weight polyethylene, porous surface orthopaedic implants, and dental 
filling composites. 
o Ceramics are widely employed in orthopaedic implants, as bone fillers, and in dental 
and ear–nose–throat implants. The most common bioceramics are aluminum oxides, 
calcium phosphates, titanium oxides, zirconium oxides, and glass–ceramics. 














Figure 1.1 - Market share of the most common classes of biomater
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1.1.2. Polymeric Biomaterials 
The interest for polymeric biomaterials and their application for medical purposes is 
growing very fast. Polymeric materials have found applications in diverse biomedical 
fields, such as ophthalmology, dentistry, orthopaedics, implantation of medical devices, 
bioartificial organs, drug delivery and many more [Jagur-Grodzinski 1999].  
Compared with other types of biomaterials, such as metals and ceramics, polymers offer 
the advantage of being engineered and processed in different ways to meet specific end–
use requirements. Besides the broad variety of commercially available polymers, the 
synergy between advanced organic chemistry and polymer synthesis has led to the 
development of precious tools for the design of polymer architecture and the grafting of 
bioactive molecules [Drotleff 2004, Hawker 2005]. Therefore, according to key “device” 
characteristics such as mechanical resistance, degradability, permeability, solubility, and 
transparency, polymers can be selected and specifically tailored for appropriate surface or 
bulk properties.  
Whereas the original uses of polymers in clinical medicine focused primarily on the 
replacements of connective tissues, new applications are emerging. Nowadays, two 
important application fields of polymeric biomaterials are tissue engineering and 
controlled drug delivery. 
Tissue engineering is aimed at restoring, maintaining, or enhancing tissues and organs 
functions by assuring synergistic interactions of living cells and synthetic materials. 
Although transplantation and reconstructive surgery are the most used therapies to address 
the loss and failure of organs and tissues, they remain imperfect solutions. Tissue 
engineering could actually afford a valid alternative [Griffith 2002].  
Drug delivery main issues are the control of the pharmacokinetics and biodistribution of 
drugs in order to restrict their action to the treated tissue and keep their concentration at 
therapeutically relevant levels for the desired time.  
Polymers are currently used as physical carriers for drugs, components of prodrugs, 
conjugates or in complexes with proteins or nucleic acids, as well as direct therapeutics in 
their own right [Twaites 2005]. The role of polymers in drug delivery covers multiple 
aspects, from the enhancement of the physical-chemical stability of the drug to the 
regulation of drug release and targeting. The goal of drug delivery and the involvement of 
polymeric biomaterials is hence to increase drug efficacy and reduce the toxicity of 
traditional drug administration, create easier dosage regimes and achieve a better patient 
compliance. [Vasir 2005].  
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As a further step towards the development of third–generation “smart” materials for 
biomedical use, the possibilities of synergistically combine the approaches of both 
conventional tissue engineering and controlled drug delivery has been recently envisaged. 
The aim of such association is to afford systems that not only constitute a supportive 
scaffold for cell proliferation, but also guide cell development and organization by 
progressive and controlled release of cell growth and differentiating factors [Saltzmann 
2002]. This concept, which could promote the formation of highly organized and complex 
tissues, is actually under investigation by the most eminent research groups involved in 
biomaterials science. 
Generally, polymeric biomaterials are classified as synthetic polymers and polymers of 
natural origin. The field of applications of synthetic and natural polymeric biomaterials is 
indeed very wide, including surgical devices, implants and supporting materials (e.g. 
artificial organs, prostheses and sutures), drug delivery systems with different routes of 
administration and design, carriers of immobilized enzymes and cells, biosensors 
components of diagnostic assays, bioadhesives, ocular devices, and materials for 
orthopaedic applications [Angelova 1999]. Biopolymers and their applications are 
summarised in Table 1.1 [Park 1992, Jagur-Grodzinski 1999, Saltzmann 2002, Kashyap 
2004, Twaites 2005] whereas synthetic polymers are summarized in Table 1.2.  
 
Table 1.1 - Natural polymers and their application. 
Polymer Main applications and comments 
Proteins and protein-base polymers Resorbable. Biocompatible and not toxic. Elastic materials 
 applied in implantology and tissue engineering. 
 Collagen Sutures, drug release. 
 Albumin Drug stabiliser and drug release. 
 Gelatin Used in the preparation of gels and in drug release 
Polyaminiacids Not toxic, not antigenic and biocompatible. Used as 
 carriers for oligomeric drugs. 
Polysaccharides and vegetal derived polymers 
 
 Carboxymethylcellulose Drug release, dialysis membranes, cell immobilisation  
  (ionotropic gelation and formation of polyelectrolyte 
  complexes) 
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 Starch Drug delivery 
 Cellulose sulphate In polyelectrolytic complexes for imunoisolation 
 Agarose Used in clinical analysis and as matrix 
 Alginate Biocompatible. Applied in gel preparation and to 
  Immobilise cell matrix and enzymes. For the release of  
  bioactive molecules, injectable microcapsules for  
  neurodegenerative diseases and hormones deficiency. 
Polysaccharides and human/animal derivatives 
 
 Hyaluronic acid Moisturizing agent,  wound dressing, artificial tears in 
  ophthalmology, in various orthopaedic applications 
 Eparin and Eparin-like Trombolytic anticoagulant properties. Used in surgery for 




 Dextran and derivatives Excellent reological properties, plasma expander. Used in  
  drug delivery. 
 Chitosan and derivatives Natural polycation. Biocompatible, not toxic. Used in gel  
  and film preparation. Applied in drug delivery. 
 
 
Table 1.22 - Synthetic polymers used for biomedical applications. 
Polymer Main applications and comments 
Aliphatic polyesters 
Poly(lactic acid), poly(glycolic acid) Used in sutures, drug delivery systems and tissue 
engineering. 
and their copolymers Biodegradable. Copolymerized to regulate degradation   
  time. 
Poly(hydroxybutirate)s Biodegradable, used as matrix for drug 
Poly(γ–caprolactone) and copolymers Delivery systems, cell microencapsulation. 
Poly(alkylene succinate), etc. Properties can be tuned by chemical modification, 
  copolymerization and blending. 
Polyanhydrides Biodegradable, useful in tissue engineering  and for 
 the releaseof bioactive molecules. 
Polyorthoesters Surface–eroding polymers. Application in 
 sustained drug delivery, ophtalmology. 
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Polycyanoacrylates Biodegradable, depending on the length of  the 
 alkyl chain. Used as surgical adhesives, glues, and 
 in drug delivery. 
Polyacrylonitrile  Dialysis membranes  
Polyphosphazenes Can be tailored with versatile side–chain   
 functionality. Applications in drug delivery. 
Polyamides Used for sutures, hemofiltration 
 membranes.Inhibitors of DNAtranscription 
Polyurethanes Used for prostheses, vascular grafts, catheters 
 tissue adhesives,artificial cardiac structures, coatings 
Polyethylene Used for orthopaedic materials and catheters. 
Polypropylene  Plasmapheresis membranes, sutures, external medical 
devices. 
Poly(methyl methacrylate) This and its copolymers are used as dental implants, in 
 bone replacement and as intraocular lenses. 
Poly(hydroxyethyl methacrylate) Used for contact lenses, ocular prostheses, skin 
 coatings, catheters. 
Polytetrafluoroethylene (Teflon
®
) Used for vascular grafts, clips and sutures facial 
 prosthes, coatings. 
Polydimethylsiloxanes Used for implants in plastic surgery,   
 orthopaedics, blood bags, 
 pacemakers, drug delivery devices, membrane 
 ossigenators. 
Poly(N-vinylpyrrolidone) in hydrogels for controlled release of drugs  from 
 metal tents,or in blood substitutes. 
Polysulfone Heart valves, penile prostheses 
Poly(vinyl chloride) Used for tubing, blood bags. 
Polystyrene Used as substrates for cell cultures. 
Poly(ethylene oxide) Different polymer derivatives and  copolymers 
 used in a variety of biomedical  applications. 
Poly(ethylene glycol) Several applications as spacer, in  bioconjugations, 
 coatings, etc. Covalently bound in Pegvisomant for 
 agromegaly;and in Pegfilgrastim to increase neutrophilis 
 production in bone marrow for neutropenia. 
Polylisine Applied in gene delivery, formation of conjugate vectors  
Polyethylenimine Applied in gene delivery, formation of conjugate vectors 
Polyamidoimine Vectors of oligonucleotide transfer and gene delivery 
 
1.1.3. Biodegradation and Bioerosion 
Biopolymers used for medical application must often be biodegradable and polymers 
degradation may occur under active or passive processes. Generally, the human body is 
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described as an aqueous environment with a pH of 7.4 and a temperature of 37°C. It is 
important to observe that actually, the physiological environment of particular organs or 
tissues may be different and it is also subjected to drastic changes in case of disease. The 
saline solution of the human body is an excellent electrolyte, which induces hydrolysis 
and corrosion processes on the implanted foreign body or to the polymeric drug carrier. 
Catalysts produced by cells and tissues may accelerate these processes as well as isolate, 
attack and destroy the implanted device. The majority of the polymers employed for the 
production of medical devices are subjected to water diffusion and consequently to 
hydrolysis reactions. The hydrophilicity of the polymer is a fundamental parameter to be 
considered in the selection of the material and it is strictly related to the final application 
of the device; i.e. it is preferable to choose bioresorbable materials for the production of 
sutures. The degradation of polymers in vivo (biodegradation) is not only related to water 
absorption but also to a complexity of factors that highly accelerate the degradation 
process. Numerous cells, e.g. the cells involved in inflammation, produce enzymes which 
catalyses some of the reactions responsible for significant alteration of the molecular 
structure of the implanted devices. In particular, phagocytes migrate to the areas of 
inflammation where the implant is located. Through specific recognition mechanisms 
(mediated by antibodies) or non-specific absorption of proteins, phagocytes adsorb on the 
surface of the foreign body. The consequence of the described behaviours is the 
enhancement of the metabolic activity and of the immune response of the body, which 
leads to the activation of the degradation processes on the implanted system. 
Biomaterial degradation is affected by both material physical-chemical properties and 
general conditions of the host (age, health, therapeutic treatments) as well as by the 
specific location of the implant and the type of the surrounding tissues. Scaffolds made of 
biostable polymers require the removal of the device once the therapeutic activity is 
exhausted and may induce a chronic inflammation. Nonetheless, when biodegradable 
polymers are employed, they should not generate harmful or immunogenic products as a 
result of their degradation. 
A polymer is considered “bioerodible” if its solubility in water changes from not soluble to 
soluble, under physiological conditions. As formerly explained, the solubilization of the 
polymer may not necessarily involve the chemical breakdown of polymer backbone but 
can simply be associated to pH changes and ionic transfers. Therefore, bioerosion includes 
both physical processes (dissolution) and chemical processes (hydrolytic cleavage of 
chemical bonds, also mediated by enzymes). The suffix “bio” imply an erosion process 
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that takes place under physiological conditions and distinguishes bioerosion from other 
degradative processes due to temperature, radiations or to the presence of either strong 
acids or bases. Biodegradation includes also the concept of bioresorption. Bioresorption 
(also called bioassorption) concerns the removal of the polymer and of its degradation 
products from the biological environment, mostly performed by cells by means of 
phagocytosis [Kohn, 1996]. The removal of solubilised polymer chains and degradation 
products may also ensue from renal excretion [Griffith, 2002b]. The bioerosion of a solid 
polymeric implant correspond to macroscopic changes of the device aspect, alterations of 
the physical-chemical properties, swelling, weight loss, shape changes and loss of 
functionality. Two different bioerosion modalities have been described in literature, 
namely bulk and surface erosions. In bulk erosion, water diffusion inside the polymer 
matrix is faster than the rate at which the polymer is converted into a water-soluble 
material. Therefore, water uptake is followed by an erosion process that occur inside the 
entire volume of the solid device. Typically, bulk erosion of polymeric materials induces 
the formation of pores that drive the physical decomposition of the device.  
Conversely, in surface erosion, water penetration inside the polymeric device is slower 
than the dissolution process on the surface. Differently from bulk erosion, the gradual 
dissolution of polymer surface has a minor but progressive influence on the shape and 
mechanical characteristics of the device.   
 
 
1.2. BIOLOGICAL EVALUATION OF BIOMATERIALS 
1.2.1. Biocompatibility and Hemocompatibility 
The fundamental characteristic of biomaterials is their capability of interacting with 
organic tissues and biological fluids without inducing secondary alterations or damaging 
processes in the host living organism. Summarising, when biomaterials are in contact with 
body tissues, they should not cause toxic, inflammatory, or carcinogenic responses 
(biocompatibility) and their interactions with blood should not elicit coagulative or cell–
disruptive activities (hemocompatibility). Until the 1970s, the term “biocompatibility” was 
related to the biological inertness of the material. At present, the concept of inertia is 
questionable because there is no material that does not elicit a response when in contact 
with body compartments. Moreover, with the improvements in material technology and 
instrumentation, new materials have appeared on the scientific scenario. The characteristic 
of such materials is to degrade in the biological tissues and release degradation products 
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that can interact “positively” with the living cells and their metabolism, thus bringing 
about favourable biological reactions for the implant life and functionality [Gatti 2002]. 
Because of this insight and development, biocompatibility was defined as “the ability of a 
material to perform with an appropriate host response in a specific application” [Williams 
1987]. 
In general, any foreign material in contact with body tissues or fluids generates a specific 
reaction. The type and level of this reaction will depend on the particular body organ 
where this reaction originates and will consist of a complex and integrated defensive 
system. In particular, a reaction of inflammatory type can occur, involving the progressive 
intervention of macrophages and leukocytes and subsequent secretion of 
mucopolysaccharides and procollagen, which will finally give rise to a fibrous tissue 
coating the foreign body. A further reaction can be of immune type, due to the antigenic 
activity exerted by the material or by its release products. Other adverse reactions can be 
represented by thrombogenesis, hemolysis, carcinogenesis or mutagenesis phenomena 
[Marconi 2002]. 
More in detail, a biocompatible material must satisfy the following requirements: 
o the material must not release soluble components, unless such release is intentional 
(e.g. controlled drug delivery systems); 
o the host organism must not degrade the implant, unless this degradation is programmed 
and desired (e.g. resorbable sutures); 
o the mechanical, physical, and chemical properties of the material must be modeled 
upon the required function and must be constant over the desired period of time; 
o the material must not be toxic, carcinogenic or theratogenic and must not negatively 
interact with the host immune system; 
o the implant must be able to undergo sterilization processes and preserve its properties. 
 
Polymeric biomaterials may be considered as constituted of mixtures of chemicals. Some 
of these chemicals are bound to the polymer backbone or held in the material matrix, while 
others are able to migrate and disperse in the biological environment, where they perform 
their functional role. Polymer matrix can also be contaminated by residuals of the solvents 
employed in both synthesis and processing of the material, as well as being constituted of 
polymers with a high polydispersity index and present chains with different molecular 
weights. The type and amount of these chemicals may determine the biocompatibility of 
the material.  
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The evaluation of the biocompatibility is hence necessary to ensure the safety of the 
product and, in order to be declared suitable for clinical application a new material must 
undergo a series of in vitro and in vivo biocompatibility tests.  
Evaluation under in vitro conditions can provide rapid and inexpensive data on biological 
interactions, minimizing the use of animals in research. However, this must be tempered 
with an appreciation that the obtained results may not be relevant to the implant situation. 
Up to now, no in vitro protocol exists that is universally considered as substitute of in vivo 
tests.  
After the in vitro assessment of tissue compatibility, materials must undergo the in vivo 
evaluation by means of animal models. Several standard procedures for the biological 
identification and quantification of the risks associated with the biomedical materials have 
been defined by the International Organisation of Standardisation [ISO 10993, ISO 1992] 
in Europe, by Food and Drug Administration (FDA) [G95-1] and the American Society for 
Testing and Materials (ASTM) in the United States. The most important assays 
(sometimes performed both in vitro and in vivo) include those aimed at the evaluation of 
hemocompatibility, in terms of hemolysis and thrombogenicity, irritation and sensitization 
effects, local effect after implantation, systemic toxicity, genotoxicity, carcinogenicity, and 
reproductive toxicity [Gatti 2002]. 
 
1.2.2. Cytotoxycity 
The term “cytotoxicity” is referred to toxic effects (death, alterations in cellular membrane 
permeability, enzymatic inhibition, etc.) at the cellular level [Ratner 1996].  
Nowadays, in vitro systems range from simple subcellular fraction, primary cultures and 
cell line, to three-dimensional organotypic cultures.  
In vitro cell culture represents certainly a powerful tool for the preliminary screening of 
biomaterials cytotoxicity. A wide variety of cell types ranging from stem cells, 
undifferentiated fibroblast like or epithelial like cells as well as highly differentiated and 
tissue specific cells can be isolated from many tissues and species, cultured over extended 
periods of time and/or cryopreserved for future use. Moreover, since most of the chemicals 
in charge for the development of diseases and death in animal and human are ultimately 
excreted at the cellular level, cultures of mammalian cells are particularly indicated for 
cytotoxicity evaluation. Cell-based assays can provide essential information on potential 
effects of chemicals on specific cell properties and provide relevant basis for further 
molecular studies [Chiellini F. 2006a].   
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The main cell culture assays for testing cytotoxicity are: 
o Direct contact with the biomaterial surface 
o Exposure of the cells to solutions of the biomaterial or to extracts of solutions in 
which the biomaterial is placed (elution), depending on the solubility of the 
material in the culture medium 
o Indirect contact via, for example a diffusion layer such as agar. 
The choice of the method varies with the characteristics of the investigated material, the 
rational for doing the test, and the application of the data for evaluating biocompatibility. 
Commonly, the interpretation of the assays is based on morphologic effects on cell 
cultures, which are classified as light, moderate or strong grade. 
When the cell culture is exposed to specific amounts of material, it is possible to evaluate 
the concentration of material that induces the 50% of cell death in respect to the control 
cell culture (IC50 value). The calculated values are useful for the establishment of the 
initial concentration of material to be employed in in vivo experiments. 
In the selection of the experimental method is important to weight the benefits and 
drawbacks of each assay, which are strictly related to the modality of the diffusion of toxic 
compounds from the tested material to the cells. 
In the direct contact and agar-diffusion methods, the diffusion of toxic products generates 
a concentration gradient that is expected arranged in concentric areas. The major 
difference between the two is that in direct contact method, the physical movement of the 
device may determine a trauma on the surrounding cells. Their morphology and vitality 
will result altered by the physical presence of the material and by the elevated 
concentration of toxic agents, if released. Despite the presence of cells in direct contact 
with the device, if the released toxic agents have good solubility in water they can diffuse 
in the culture medium and hence influence the entire cell population.  
In the agar-diffusion method the diffusion of the toxic compounds is still occurring but the 
physical trauma is prevented. 
In the elution tests, the interpretation of the assay considers the entire cell population. In 
this case, the toxic compounds are uniformly distributed in the plate and capable of 
affecting the entire cell population. Generally, a deeper experience in morphology 
evaluation is required when the elution tests are performed.  
The assay that involves the direct contact of the cells with the surface of the material 
mimics the clinical application of a device in a biological fluid, e.g. placed in the blood 
compartment. Aimed to a better reproduction of the physiological conditions, the material 
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is directly located in a serum containing cell medium and kept at 37°C. In vivo, the 
proteins of the serum are responsible for the transport of insoluble compound in the blood. 
Similarly, when involved in the in vitro assays they are thought to enhance the 
solubilization of the substances extracted or released from the material. The direct contact 
assay is useful for the evaluation of specific surface geometries of a manufactured device 
as well as for the study of the raw material.   
In all the methods described, the quantitative evaluation of cytotoxicity can be performed 
by means of chromogenic assays. Cell response to the presence of the exgoneous material 
is usually measured in terms of cell vitality, proliferation and metabolic activity 
(Tetrazolium salts), cell membrane damage (LDH release) and endocytosis capability 
(Neutral Red).  
A significant role is also played by cell adhesion on the biomaterial surface. Depending on 
the final application of the device, cell adhesion may be desirable or not. Chemical and 
physical factors, such as material surface charge, wettability, topography exposure of 
specific moieties, can affect cellular adhesion. Recently, new techniques for the evaluation 
of cytocompatibility in terms of cell adhesion have been reviewed. Immunochemistry, 
spectrophotometric analysis and image analysis have been applied [Manso 2002, Owen 
2005].  
The arising of positive or negative false results in cytotoxicity assays can be obviated by 
an accurate morphological investigation, performed by means of different techniques, such 
as optical microscopy, confocal laser microscopy, epifluorescence, scanning electron 
microscopy and trasmission electron microscopy. 
When the cytotoxicity profile of a material has been determined, application–specific tests 
are then performed to assess the biocompatibility. Current experience indicates that a 
material that is judged non-toxic in vitro will be non-toxic by in vivo assays. This does not 
necessarily mean that materials that are toxic in vitro could not be used in a given clinical 
application. The clinical acceptability of a material depends on many different factors, of 
which target cell toxicity is but one. 
 
1.2.3. Genotoxicity 
A material is defined mutagenic when it determines an increase of the number of 
mutations in specific genes and/or in entire chromosomes. Presently, in vitro methods for 
the quantitative evaluation of genotoxicity are not well developed. The most applied test 
aimed at the evaluation of genotoxicity is Ames test. This test verifies the mutagenic 
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potential of a material on cell culture by comparison to a well know genotoxic material, 
applied as positive control, and a negative control [Gatti 2002]. 
The advances in genomic and proteomic will lead to deeper investigation of gene 
expression profiles at either the transcriptional or translational level, with expression 
profiles specifically related to the tested material or extracts [Butte 2004, Carpenter 2004]. 
 
1.2.4. Hemocompatibility 
Blood is a complex tissue with particular chemical, biological and biomechanical features. 
Blood is composed of a multitude of cell types that participate in a vast array of functions, 
including tissue repair and immune responses as well as oxygen transport. Moreover, blood 
also contains several soluble multicomponent protein systems that systematically interact in 
various ways to perform key functions. Because of the range and criticality of these 
functions, any source of cytotoxicity to blood cells or significant interaction with serum 
proteins can cause considerable harm.  
The sensitiveness of blood to the presence of a foreign body is appreciable also when it is 
withdrawn. Its properties and functionality may change with the extraction modality and 
affected by the chemical surface of the container. The reliability and reproducibility of in 
vitro hemocompatibility tests is therefore inadequate and do not predict the real 
hemocompatibility of the material [Gatti 2002]. 
 
 
1.3. TISSUE ENGINEERING 
1.3.1. Definition and Aim of Tissue Engineering 
Tissue engineering is a multidisciplinary field which involves the application of the 
principles and methods of engineering and life sciences toward the fundamental 
understanding of structure-function relationships in normal and pathological mammalian 
tissues and development of biological substitute that restore, maintain or improve tissue 
function [Shalak 1988]. Tissue engineering has the potential to produce a supply of 
immunologically tolerant artificial organ and tissue substitutes that can grow with the 
patient. This should lead to a permanent solution to the damaged organ or tissue without 
the need for supplementary therapies, thus making it a cost-effective treatment in the long 
term [Patrick 1998]. The loss or failure of an organ or tissue is one of the most 
devastating and costly problems in human health care [Langer 1993]. Tissue engineering 
has the potential to revolutionize methods of health care treatment to improve the quality 
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of life for many [Sipe 2002, McIntire 2003, Williams 2004]. Its goal is to surpass the 
limitations of conventional treatments based on organ transplantation [Langer 1993]. The 
in vitro generation of engineered tissue constructs typically starts with the attachment of 
isolated cells into to three-dimensional polymer scaffolds.  In general, the ideal approach 
for undertaking engineered tissue substitutes involves the subsequent procedure. First, the 
biological cells are identified and gathered in sufficient numbers. Second, the suitable 
biomaterial is identified and designed accordingly to host the gathered cells. Finally, the 
cells are seeded into the biomaterial for cell culturing in vitro or in vivo. This stage is 
commonly referred to as “cell seeding”. The requirements for successful cell seeding 
include high efficiency (which can be through of as the ratio of attached cells to seeded 
cells), fast attachment of cells to scaffolds, high cell survival and uniform spatial 
distribution of cell throughout the scaffold volume. It is widely accepted that the 
efficiency and the spatial distribution of cell attachment to scaffolds during cell seeding 
influence the cell density (number of cells per construct unit or volume) of engineered 
tissue constructs, which in turn impacts the kinetics of cell proliferation and extracellular 
matrix deposition, and these affect construct functionality [Bueno 2007]. Several 
requirements have been also identified as crucial for the production of the tissue 
engineering scaffolds [Hutmacher 2000]: (1) the scaffolds should posses interconnecting 
pores of appropriate scale to favour tissue integration and vascularisation, (2) be made 
from material with controlled biodegradability or bioresorbability so that tissue will 
eventually replace the scaffold, (3) have appropriate surface chemistry to favor cellular 
attachment, differentiation and proliferation, (4) posses adequate mechanical properties to 
match the intended site of implantation and handling, (5) should not induce any adverse 
response and (6) be easy fabricated into a variety of shapes and sizes. Several materials 
have been adopted or synthesized and fabricated into scaffolds [Drury 2003]. In addition, 
an advanced fabrication system to manufacture such designed scaffold in order to achieve 
the consistency and repeatability in accordance to the initial design is required. The 
strategy of cellular tissue engineering has focused on manipulating the cell environment 
by modulation of cell-extracellular matrix (ECM) and cell-cell interactions. The EMC 
may influence cell behavior through it material properties, surface treatment, degree of 
porosity, and pore size. Controlling each of these environmental influences has been used 
to facilitate the development of functional tissue [Bhatia 1997]. In addition, the size and 
the geometry of these pores to be designed within the scaffolds is also important to the 
INTRODUCTION 
 15 
cell behavior and has always been one of the key parameters in the design of ECM 
scaffold [Patel 1998].  
 
 
Figure 1.2 -  Tissue engineering strategy. 
 
 
1.3.2. The Biological Environment 
The design of new biomaterials requires the combination of knowledge or collaboration 
among scientists from different field such as biology, medicine, pharmaceutical sciences, 
chemistry, physics and material science. In practice, this new biomaterial development 
often takes a biomimetic approach by looking into a natural processes to examine how the 
desired functions can be achieved, by understanding these principles and by using them in 
designing functional biomaterials [Healy 1999]. The selection of biomaterials as EMC 
substitute depends on the type of tissue that is to be regenerated [Seal 2001]. In particular, 
a deep investigation of the chemical and of the biological characteristics of the 
environment in which the material is expected to perform its actions is of utmost 
importance. The knowledge of biological environment may allow for a better 
understanding of which are the main factors that determine the final performances of 
materials, therefore allowing for the optimization of their design. 
 
1.3.2.1. Extracellular matrix (EMC) composition  
The insoluble non-cellular material present among cells throughout the body of 
multicellular organisms is known as the extracellular matrix (EMC). This matrix  is 
composed of 3 major classes of biomolecules: (1) structural proteins: collagen and elastin, 
(2) specialized proteins:  fibrilin, fibronectin, and laminin (3) proteoglycans composed of 
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proteins core to which is attached long chains of repeating disaccharide units termed of of 
glycosaminoglycans (GAGs) forming extremely complex high molecular weight 
components of the EMC. It is worth noting that the composition directly modulates all 
ECM characteristics, such as viscosity, strength, and mechanical resistence, which are 
finely tailored to the functions of the tissue. Due to its diverse nature and composition, the 
EMC can serve many functions, such as providing support and anchorage for cells, 
segregating tissues from one another, and regulating intercellular communication. The 
ECM regulates a cell’s dynamic behavior and sequesters a wide range of cellular growth 
factors, and acts as a local depot from them. Cell can be directly connected to the EMC 
backbone by the interactions of specific receptors with glycoproteins bound to EMC 
itself. Fibronectin, vitronectin, and laminin are connection glycoproteins that play a major 
role in the signaling and selective site recognition mechanism of cell adhesion. The cell 
surface also possesses receptors, namely integrins, which bind the connection proteins, 
allowing for the effective adhesion to ECM.  
 
1.3.2.2. Integrins 
The integrin trasmembrane receptors are heterodimeric molecules composed of α and β 
subunits, with extracellular domains which bind the EMC, and cytoplasmatic domains 
which associate with the actin cytoskeleton and affiliated proteins, including vinculin, 
talin and alfa-actin [Burridge 1996, Dedhar 1996] (Figure 1.3). Thus, as their name 
implies, integrins create an integrated link between the outside and the inside of the cell. 
At least 16 α and eight β subunits have been identified, which could potentially generate 





Figure 1.3 - Integrin structure. 
 
Integrin receptor exibit considerable overlap in their ligand-binding specificities. For 
example, the αvβ3 vitronectin receptor shows strong binding affinity to fibronectin, 
collagen, tenascin C, thrombospondin and fibrinogen [Cheresh 1984]. Furthemore, 
particular EMC components can bind to more than one integrin. This may suggest that 
different integrins perform specialized signaling functions. Various combination of α and 
β chains result in constitution of receptors with preferential affinity to certain ECM 
molecules. Integrins also bind specific amino sequences such as the arginine-glycine- 
aspartic acid (RGD) recognition motif present in many ECM proteins, including 
fibronectin and vitronectin. The possibility of binding RGD to different receptors is 
probably caused by a different spatial conformation of RGD due to the vicinity of 
different amino acids or existence of different synergistic sequences on various ECM 
molecules. Integrin play central roles in development and the organization, maintenance, 
and repair of various tissues by providing anchorage and triggering signals that direct cell 
survival, migration, cell cycle progression, and expression of differentiated phenotypes 
[Danen 2003]. Integrin-mediated adhesion is highly regulated, complex process involving 
receptor-ligand binding as well as post-ligation interactions with multiple binding 
partners. Upon ligand binding, integrins rapidly associate with the actin cytoskeleton and 
cluster together to form focal adhesions, discrete supramolecular complexes that contain 
structural proteins, such as vinculin, talin, and α-actinin, and signaling molecules [Geiger 
2001]. These focal contanct are central elements in the adhesion process, functioning as 
structural links between the cytoskeleton and EMC. Due to the anchoring of actin 
filaments into focal adhesion, the latter are involved in organization of the cytoskeleton 
and consequently in cell shape [Watt 1988]. Migration of cells can occur by way of a 
cycle of focal contact release and assembly at the rear and front of the cell, respectively 
[Regen 1992]. Furthemore, the adhesion assemblies are suggested to be involved in the 
responses of cells to shear [Girard 1995, Kim 1997]. Furthermore, in combination with 
growth factor receptors, these adhesive clusters activate signaling pathways that regulate 
transcription factor activity and direct cell growth and differentiation [Haney 2002, 
Geiger 2001]. Moreover, integrins are important regulators of cellular and host response 
to implanted devices, biological interaction of biomterials and tissue engineering 
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constructs, and the performance of cell arrays and biotechnological cell culture supports 
[Anderson 2001, Vreeland 2002, Lutolf 2005]. 
 
1.3.3. Cell Interactions with Polymer Surfaces 
The interactions of cells with polymers may be investigated in vitro by cell culture 
techniques. Although in vitro experiments only partially reproduce the complex cellular 
responses that occur following the implantation of materials, culture experiments 
guarantee for a degree of control and quantification that can not be easily obtained in 
vivo. The general approach involves deposition of cultured cell on the polymer surface 
followed by the determination of some important biological parameters, mainly cell 
adhesion and successive spreading. Indeed, most tissue-derived cells such as fibroblasts 
[Saltzman 1997] require attachment to a solid surface growing, and the initial events that 
occur when a cell approaches a surface are of fundamental interest. In the prospective of 
complete tissue regeneration, cell migration and cell aggregation are two further 
important parameters to assess the viability and functionality of cells over a polymer 
surface. Many procedures allow for a qualitative evaluation of the extent of cell adhesion 
and proliferation, making use of a variety of experimental techniques that measure 
different physical-chemical properties (i.e. radioactivity, fluorescence, enzyme activity) 
[Saltzman 1997]. 
 
1.3.3.1. Cell behaviour on bioactive polymer structures 
In the past few decades biomaterials have been involved from off-the-shelf materials 
originally developed for applications unrelated to biomedicine to biomaterials specifically 
designed for particular applications and exhibiting intended biomedical functions [Peppas 
1994]. The design of new biomaterials requires the combination of knowledge or 
collaboration among scientists from different fields such as biology, medicine, 
pharmaceutical science, chemistry, physics and materials science. In practice, this new 
material development often takes a biomimetic approach by looking into natural 
processes to examine how the desired functions can be achieved, by understanding these 
principles and by using them in designing new functional biomaterials [Healy 1999]. The 
design and the synthesis of polymer materials with ability of molecular recognition can be 
regarded as the exhibit of this biomimetic approach. Cell adhesion to synthetic surfaces is 
crucial to many biomedical and biotechnological applications [Langer 1993, Anderson 
2001, Hubbell 1999]  
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No general principle that would allow for the prediction of cell attachment to different 
polymer surface have been clearly identified. However, interesting relationships with 
some surfaces characteristcs were proposed. Cell adhesion is apparently maximized on 
surface with intermediate wettability [Saltzman 1997, Van Wachem 1985, Atlankov 
1996]. Following this interpretation, some authors introduced the concept of equilibrium 
water content (EWC) and showed that cell adhesion is apparently related to this 
physiochemical parameter [Van Wachem 1985]. However, other groups evidenced that 
cell adhesion strongly depends upon individual functional groups, rather than on general 
surface characteristics such as wettability [Salzman 1997, Webb 2000]. In almost all 
cases, cell adhesion to biomaterial surface is mediated by a layer of adsorbent proteins, 
such as immunoglobulins, vitronectin, fibrinogen and fibronectin (FN) [Brash 1987, 
Grinnell 1980]. Numerous studies have shown that type, quantity and activity of 
adsorbent proteins are influenced by the underlying substrate proprieties, including 
chemistry and hydrophobicity [Brash 1987, McClary 1999, Tengvall 1998]. These 
substrate-dependent differences in protein adsorption have profound effects on cellular 
activities, including receptor binding and subsequent cell adhesive events [17-23]. Indeed, 
in vivo cellular adhesion and other correlated functions are mediated through ECM 
components. Similarly, in vitro most cell display adhesion, spreading, and growth only if 
the culture medium contains biological serum, consisting of many ingredients that are 
typical of natural EMC. This effect has been explained by considering that cell 
attachment may processed by four steps mechanism [Schackenraad 1996]. 
1) In a short time (seconds to minutes) a thin film of protein as adsorbed over the 
surface; 
2) Cells approach the surface driven by diffusive or active mechanisms  
3) Cell recognize and adhere to the protein layer 
4) Cell spread, because of continuing adhesion and cytoplasmatic contractile 
meshwork activity (Figure 1.4). 
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Figure 1.4 - Cell-polymer interaction. 
Protein adsorption to the surface is irreversible, and this behavior is consistent with the 
hypothesis that each cell is linked to the protein surface by multiple bonds. The 
adsorption process is very complicated, and it has been proposed that is made of two fast 
sequential phases. [Andrade 1986]. First, the protein reversibly interacts with only a 
limited number of surface sites. Later on, a partial conformational change occurs, as a 
consequence of strong interactions with specific surface sites, resulting in a nearly 
irreversible protein-surface association [Horbett 1996]. This strong adhesion literally 
blocks the structure and the position of the protein, avoiding its diffusion toward the bulk 
domains if the material [Horbett 1996]. The surface chemistry of a material also plays a 
significant role in cell adhesion to the surface which increases the cell’s ability to attach 
and spread. Properties such as surface roughness, hydrophobicity, can direct cell activity 
[Saltzman 2000]. The modulation of cell activity through substrate interaction can have a 
significant effect on biomaterial-based therapies. The complex surfaces associated with 
biological recognition are effective in controlling biological responses. Thus, to address 
this issue, efforts have focused on modifying surfaces to control protein interaction and to 
decorate the surface appropriately with signaling molecules. A number of short peptide 
sequences derived from adhesive EMC proteins have been identified that are able to bind 
to cell surface receptors and mediate cell adhesion with affinity and specificity similar to 
that obtained with interacts proteins. The most extensively studied cell adhesion peptide is 
the sequence Arg-Gly-Asp (RGD). It is found in many cell adhesion proteins and bind to 
integrine receptors on a wide variety of cell types [Humphires 1990]. Modification with 
RGD preptides may enhance cell adhesion to a biomaterial and activate integrin signaling 
pathways. The study of these complex interactions, in terms of receptor analysis and 
adhesion mechanisms is of primary interest for understanding how to bind cellular 
substrates without damaging the cells. From a tissue engineering perspective, a detailed 
INTRODUCTION 
 21 
analysis of ECM-cell interactions represents the starting point of very investigation. This 
knowledge is crucial for the realization of cell scaffolds that are proper substrate for cell 
survival, differentiation, and maintenance [Matins-Green 1997]. It is clear that the surface 
of the material has a primary function in determining the success of the biomaterial, 
because it is first one to interact with the body environment.  
 
 
1.4. HYDROGELS  
1.4.1. Structural Characteristics 
Hydrogels are three dimensional hydrophilic polymer networks capable of swelling in 
water or biological fluids, and retaining a large amount of fluids in the swollen state 
reaching up to thousands of times their dry weight; they could be either synthetic or 
natural. A variety of synthetic and naturally derived materials may be used to form 
hydrogels for tissue engineering scaffolds. Their ability to absorb water is due to the 
presence of hydrophilic groups such as -OH, -CONH-, -CONH2, -COOH, and -SO3H 
[Satish 2006]. The structural integrity of hydrogels depends on the crosslinking of the 
polymer molecules that could be bonded physically or chemically [Hoffman 2002]. 
Hydrogels may be chemically stable or they may degrade and eventually disintegrate and 
dissolve. They are called reversible, or physical gels when the networks are held together 
by molecular entanglements, and/or secondary forces including ionic, H-bonding or 
hydrophobic forces. All these interactions are reversible and can be disrupted by changes 
in physical conditions such as ionic strength, pH, temperature, application of stress, or 
addition of specific solutes. Hydrogels are called ‘permanent’ or ‘chemical’ gels when 
they are covalently-crosslinked networks. Chemical hydrogels may also be generated by 
crosslinking of water-soluble polymers, or by conversion of hydrophobic polymers to 
hydrophilic polymers plus crosslinking to form a network (Figure 1.5). 
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There are many different macromolecular structures that are possible for physical and 
chemical hydrogels. They include the following: crosslinked or entangled networks of 
linear homopolymers, linear copolymers, and block or graft copolymers; polyion–
multivalent ion, polyion–polyion or H-bonded complexes; hydrophilic networks 
stabilized by hydrophobic domains; and IPNs or physical blends. Hydrogels may also 
have many different physical forms, including  
 solid molded forms (e.g., soft contact lenses)  
 pressed powder matrices (e.g., pills or capsules for oral ingestion) 
microparticles (e.g., as bioadhesive carriers or wound treatments),  
 coatings (e.g., on implants or catheters; on pills or capsules; or coatings on 
the inside capillary wall in capillary electrophoresis),  
 membranes or sheets (e.g., as a reservoir in a transdermal drug delivery 
patch; or for 2D electrophoresis gels),  
 encapsulated solids (e.g., in osmotic pumps)  
 liquids (e.g., that form gels on heating or cooling). 
The character of the water in a hydrogel can determine the overall permeation of nutrients 
into and cellular products out of the gel. When a dry hydrogel begins to absorb water, the 
first water molecules entering the matrix will hydrate the most polar, hydrophilic groups, 
leading to ‘primary bound water’. As the polar groups are hydrated, the network swells, 
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and exposes hydrophobic groups, which also interact with water molecules, leading to 
hydrophobically-bound water, or ‘secondary bound water’. Primary and secondary bound 
water are often combined and simply called the ‘total bound water’. After the polar and 
hydrophobic sites have interacted with and bound water molecules, the network will 
imbibe additional water, due to the osmotic driving force of the network chains towards 
infinite dilution (Figure 1.6),. This additional swelling is opposed by the covalent or 
physical crosslinks, leading to an elastic network retraction force. Thus, the hydrogel will 
reach an equilibrium swelling level. The additional swelling water that is imbibed after 
the ionic, polar and hydrophobic groups become saturated with bound water is called 
‘free water’ or ‘bulk water’, and is assumed to fill the space between the network chains, 
and/or the center of larger pores, macropores or voids. As the network swells if the 
network chains or crosslinks are degradable, the gel will begin to disintegrate and 
dissolve, at a rate depending on its composition. It should be noted that a gel used as a 
tissue engineering matrix may never be dried, but the total water in the gel is still 
comprised of ‘bound’ and. ‘free’ water 
 
 
Figure 1.6 - Schematic representation of swelling process. 
 
The amount of water in a hydrogel, i.e. the volume fraction of water, and its free versus 
bound water character will determine the absorption (or partitioning) and diffusion of 
solutes through the hydrogel. Pores may be formed in hydrogels by phase separation 
during synthesis, or they may exist as smaller pores within the network. The average pore 
size, the pore size distribution, and the pore interconnections are important factors of a 
hydrogel matrix that are often difficult to quantify, and are usually included together in 
the parameter called tortuosity [Hoffman 2001]. The properties of hydrogels have made 
them attractive in the medical field, such as in drug delivery and controlled realease. As 
alternative to hydrophobic materials that may go under severe conditions, hydrogels offer 
an entreating opportunity to seed living cells and other biological species during 
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fabrication process of scaffolds [Jen 2000]. In tissue engineering applications, hydrogels 
are preferred to be biodegradable so that encapsulated cell may proliferate and form a 
tissue constructs that eventually take place of the initial hydrogel scaffolds. 
 
1.4.2. Hydrogels as Matrices for Tissue Engineering 
Hydrogels have become increasingly studied as matrices for tissue engineering [Lee 
2001]. These matrix designed for use as tissue engineering scaffolds may contain pores 
large enough to accommodate living cells, or they may be designed to dissolve or degrade 
away, releasing growth factors and creating pores into which living cells may penetrate 
and proliferate [Hoffman 2002].  The microstructure and internal architecture of scaffolds 
play an important role in not only the behavior of the cultured cells and their health, but 
also influencing cell shape modeling and gene expressions that relate to cell growth to 
specific tissue [Leogon 2003, Freyman 2001]. One significant advantage of hydrogels as 
tissue engineering matrices is the biocompatibility due to their capability to simulate 
natural soft tissues, especially for high water content, soft surface and high permeability 
for small molecules such as O2 and metabolites. Hydrogels also may covalently 
incorporate cell membrane receptor peptide ligands, in order to stimulate adhesion, 
spreading and growth of cells within the hydrogel matrix. However a significant 
disadvantage of hydrogels is their low mechanical strength, posing significant difficulties 
in handling [Hutmacher 2001]. Since hydrogels are used as matrices for many tissue 
engineering applications such as scaffolds and encapsulation of living cells they often 
required that gels degrade slowly under physiological conditions. Crosslinks have to be 
present in a hydrogel in order to prevent dissolution of hydrophilic polymer chains in an 
aqueous environment. A great variety of methods to establish crosslinking has indeed be 
used to prepare hydrogels. Since it is advantageous for many applications that the 
hydrogels are biodegradable, labile bonds are frequently introduced in gels. These bonds 
can be present either in the polymer backbone or in the crosslinkers used to prepare gel. 
The labile bounds can be broken under physiological conditions either enzymatically, in 
most of the cases by hydrolysis [Park 1993]. It is extremely important to have control 
over the parameters by the which the degradation characteristics can be tailored. Thus, 
different types of crosslinkers both chemical and physical, are usually employed in 
hydrogel preparation in order to modulate their dissolution kinetic. However, these 
crosslinkings agents could be toxic and not suitable to use in combination with cells. 
Indeed, they could not only affect the integrity of substances to be entrapped (e.i. 
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proteins, cells), but are often toxic compounds which have to be removal/extracted from 
the gels before they can applied. It appears clear that the choice of crosslinker to use for 
hydrogel formulation become extremely important.  It is clear also that there are both 
significant advantages and disadvantages to the use of hydrogels in tissue engineering, 
and the latter will need to be overcome before hydrogels will become practical and useful 
in this exciting field. 
 
 
1.5. HEPATIC TISSUE ENGINEERING  
1.5.1 Liver Functions 
Liver represent one of the most important organs of the human body and display a 
complex architecture composed of different types of cells such as hepatocytes,  stellate 
cells, Kuppfer cells and other. It plays a major role in metabolism and performs number 
of functions in the body, including glycogen storage, decomposition of red blood cells, 
plasma protein synthesis, detoxification, and bile production, an alkaline compound 
which aids in digestion via the emulsification of lipids. It also performs and regulates a 
wide variety of high-volume biochemical reactions requiring very specialized tissues. 
Because of its central role in the metabolism acute liver failure patients have a high risk 
of mortality. Hepatic tissue engineering describes efforts that attempt to harness the 
function of liver cells (hepatocytes) for therapeutic applications. 
 
1.5.2. Alternative Strategies to Liver Transplantation 
Although treatment of liver disease has been greatly improved, the elective treatment for 
liver disease still remains the orthotopic liver transplantation. Donor organ scarcity and 
the associated high costs make transplantation possible for only about one third of the 
patients on the transplantation waiting list. Engineering a biological liver substitute is an 
interesting alternative to the traditional acute liver failure therapy. Two-or three 
dimensional non-implantable constructs may be used ex vivo to support a patients until a 
tissue compatible organ is available or the patient’s own liver heals. These constructs are 
expected to provide the patients only with the relevant liver functions that stop 
progression of the damages and promote liver regeneration, and function for a limited 
time from a few weeks to a few months. Non-implantable three-dimensional constructs 
may be also useful to investigate liver cell metabolism. Over the years, research has 
mainly focused on the development of the new culture technique or new immortalized 
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hepatic cell lines. A major obstacle to the generation of functional substitutes is the 
limited understanding of the role of specific physical-chemical parameters on tissue 
development. In fact, the liver is a highly structured organ with many distinct cell sub-
populations spatially organized to optimize communication and transport. The signal that 
cells exchange promote differentiation, proliferations and functions [Mooney 1992, 
Goulet 1988, Crossin 2003] and then the regeneration of liver tissue.  
Several extracorporeal bioartificial liver (BAL) devices are currently being evaluated as 
an alternative or adjunct therapy for liver disease. Over the years, many extracorporeal 
artificial liver support devices have been proposed as a bridge to support a patient until 
the transplantation. In particular, has been examined the development of human 
hepatocyte cell lines, strategies to stabilize the hepatocyte phenotype in vitro, and 
emphasize the importance of the cellular microenvironment in bioreactor design. In these 
device, perm-selective membranes or adsorption cartridges are used to simulate the liver 
detoxification functions and remove from the blood some of the putative toxins damaging 
the liver. But the enormous number of hepatocytes required to use bioartificial liver 
devices is clinically problematic due, for example, to the insufficient good-quality human 
liver tissue from which the hepatocytes derived. In this respect, in the latest decade, the 
research is focused on development of biological substitutes based on living cells and 
bioactive polymer matrix.  
  
1.5.2.1.Tissue-engineering constructs 
Since the practical application of implanting few hepatocytes to proliferate and replace 
functions not yet possible, hepatocytes tissue construction, using polymer as a scaffold, 
relies on transplanting a large number of hepatocytes to allow survival of enough 
hepatocyte mass to replace function. The large surface area of the polymer accommodates 
hepatocytes attachment in large numbers so that many cells may survive initially by 
diffusion of oxygen and other vital nutrients. The polymer scaffolds is constructed with a 
high porosity to allow the vascular ingrowth, and vascularization of surviving cell then 
can provide permanent nutritional access [Cima 1991]. Hepatocytes adhere to the 
polymer matrix for growth and differentiation as well as locate into the interstices of 
polymer. The polymer-hepatocyte interface can be manipulated with surface proteins such 
as laminin, fibronectin, and growth factor to improve adherence, viability, functions, on 
growth [Mooney 1992]. For all these reasons it appear clear that the design and selection 
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of polymeric materials is a basic feature for the preparation of biological construct for 
tissue engineering applications.  
 
 
1.6. NATURAL POLYMERS IN LIVER TISSUE ENGINEERING 
Naturally derived polymers forming hydrogels are widely used in tissue engineering 
applications because they have macromolecular properties similar to the natural EMC. 
The usually low manufacture cost of biopolymers, related to their large availability and 
renewability, are additional advantages. Furthemore, their versatility of chemical 
structures and their well-know chemistry allows for the development of advanced 
functionalized materials that can match several varied requirements. In the biomedical 
field, the degradation of natural polymers into physiological metabolites makes them 
excellent candidates for a wide range of applications in tissue engineering. The high 
degree of diversity in functional properties has made natural polysaccharides 
indispensable partners for many tissue engineering applications. They can have an almost 
unlimited variety of chemical structures, with different sugar composition, anomeric 
configuration and position of linkages, repeating sequence, degree of polymerization, and 
charge density. The present work has been focused both on the investigation of 
commercial alginate as suitable material for scaffolds preparation,  and on  a new type of 
alginates, called Ulvans. These new material appear to be of interest because of its 
availability from a renewable resource such as Green Algae (Ulva Armonicana), an 
unlimited biomass of marine origin which for its peculiar characteristics, represent a 
suitable material to use in alternative to commercial alginate. 
 
1.6.1. Commercial Alginate 
Alginate is one of the most studied and applied polysaccharide polymer in tissue 
engineering and drug delivery field. They are abundant in nature and are found as 
structural components of marine brown algae (Figure 1.7) and as capsular 
polysaccharides in some soil bacteria. Commercial alginates are extracted from three 
species of brown algae. These include Laminaria hyperborean, Ascophyllum nodosum, 
and Macrocystis pyrifera in which alginate comprises up to 40% of the dry weight 
[Malafaya 2007]. It is a naturally derived linear polysaccharide comprised of (1-4)-linked 
β-D- mannuronic acid (M units) and α-L-guluronic acid (G units) which vary in 
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proportion and sequential distribution along the polymer chain [Drury 2004]. Within the 
alginate polymer, the M and G monomers are sequentially assembled in either repeating 
(MM or GG) or alterning (MG) blocks (Figure 1.8). The amount and distribution of each 
monomer depends on the species, section, and age of seaweed from which the alginate is 
isolated [Eiselt 2000].  
 
 
Figure 1.7 - Macrocystis pyrifera spp. 
 
 
Figure 1.8 - Schematic diagram of β-D- mannuronic acid (M units) and α-L-guluronic acid 
(Gunits), and sodium alginate. 





Alginate and its gels have found numerous and disparate applications. It has historically 
been most widely used in the food industry. It has found utility as a stabilizer and an 
emulsifier, because of its inherent properties and the interactions of alginate with proteins, 
fats, or fibers or as food for low-calories content. This polymer is also widely applied in 
the pharmaceutical industry as an excipient for drugs, a dental impression material, and 
the wound dressing [Augst, 2006] but it shows high potentiality in tissue engineering 




Figure 1.9 -  Schematic representation of hydrogel preparation. 
 
Alginate forms hydrogels in the presence of multivalent cations (i.e., Ca
2+
) through the 
ionic interaction between the carboxylic acid group located on the polymer backbone and 
the chelating cation [Eiselt 2000] (Figure 1.9). The three dimensional network resulting 
from the ionic interaction between adjacent chains is described by egg-box model (Figure 
1.10). The strength of this network depends on the overall fraction of guluronic acid 
residues, the molecular weight of the polymer, and Ca
2+
 ion concentration at the time of 
gelation. The physical properties of alginate gels vary widely depending on their chemical 
composition. Alginates containing a high guluronic acid content develop stiffer, more 
porous gels which maintain their integrity for longer periods of time [Oca-Cossio 2005]. 
During cationic crosslinking, they do not undergo excessive swelling and subsequent 
shrinking, thus they better maintain their form [De Vos 1996]. Conversely, alginates rich 
ROSALBA DECARLO- PHD THESIS 
 30 
in mannuronic acid residues develop softer, less porous gels that tend to disintegrate with 
time. Alginates with a high mannuronic acid content are also plagued by a high degree of 
swelling and shriking during cationic crosslinking [De Vos 1996].  
 
Figure 1.10 - Egg-Box Model. 
 
It is important to note that ionically crosslinked alginates lose their mechanical properties 
over time in vitro, presumably due to an outward flux of crosslinking ions into the 
surrounding medium [Shoichet 1997]. However, alginate matrices optimized for 
particular cellular functions may then be utilized as cell transplantation matrices to 
control tissue formation in vivo [Rowley 1998]. 
 
1.6.2 Ulvan 
Knowledge about plant cell wall organisation has definitely improved over the past few 
years thanks to the interface between biology, chemistry, and structural studies. Algae 
offer a clean and renewable alternative to polysaccharides source. The search for new 
functional polymers from large and undeveloped biomasses led scientists to study the 
characteristics of the cell wall polysaccharides from green algae, considered renewable 
resource. In general, a natural resource qualifies as a renewable resource if it is 
replenished by natural processes at a rate comparable to its rate of consumption by 
humans or other users. In the present work, particular attention has been posed on 
Ulvanes, an alginic material derived from renewable resource such as Green Algae, Ulva 
armoricana. Ulvan represent an interesting material for the preparation of substitute 
manufactures to use in tissue engineering applications in alternative to commercial 
alginate.Marine green seaweed from the Ulvaceae family, represented from the main 
genera Ulva, is very common seaweeds distributed worldwide (Figure 1.11). Part of this 
biomass arises from algae proliferation as a consequence of the eutrophication of costal 
water [Briand 1991]. The opportunistic growth ability of these seaweeds causes 





Figure 1.11 - Ulva armoricana spp. 
 
When these algae die and accumulate on the sea bottom or beach, the large amount of 
their bodies are spoiled and cause destructive damages to benthic ecosystem. Problems 
due to the alteration of environment are partially solved by collecting the plants. 
Unfortunately, the seaweeds have little value and are used either as compost [Morand 
1991] or poultry feed [Briand 1991] but are often simply dumped. It is also possible that 
they could be used as food (sea vegetable) since they are low-calorie and rich in vitamins, 
trace elements and dietary fibre [Ito 1993]. Seaweeds, widely used for centuries 
traditionally in Asia and marginally in the rest of the world mostly as food [Darcy-Vrillon 
1993], have been recently authorized for human consumption in France as vegetables. But 
in the western countries, these are essentially used for the production of valuable 
chemicals and polysaccharides are the major chemical compound. The use of these 
carbohydrates polymers span from food, cosmetic and pharmaceutical industries to 
microbiology and biotechnology [Franz 2000]. With today’s interest in new renewable 
sources of chemicals and polymers, this underexploited biomass represent around 38-54% 
of the dry algal matter [Lahaye 2007]. One particularly interesting feature of Ulvan is 
their richness in polysaccharides [Lahaye 2007], a phycocolloids commonly indicate with 
the name of Ulvan.  
The pioneering work of Branding et al and McKinnel and Percival  of this water soluble 
anionic polysaccharides, estabilished that sulphate, rhamnose, xylose, and glucuronic acid 
are the main constituents of ulvan, arranged in a essentially linear fashion [Percival 1963]. 
The presence of limited and regular sequence called aldobiuronic A3S and B3S sequences 
(Figure 1.12), can vary depending of the source and on the year period of the collection of 
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the algal material. The aldobiuronic blocks of Ulvan are identified as sulphated 





Figure 1.12 - Ulvan structure. 
 
 
One of the main features of such polysaccharides is therefore the presence of uncommon 
sugars as iduronic and sulphated rhamnose [Paradossi 2002]. Moreover, these blocks have 
a close similarity with mammalian glycosamminoglycans [Perlin 1971] already used for 
their antithrombotic activity such as heparin and hepara sulphate. In this respect sulphated 
marine polysaccharides represent an alternative as substitutes to heparin whose isolation 
from mammalian source like bovine intestinal mucosa can be subjected to the risk of 
contamination with BSE [Alban 2002]. Although the bioactivity properties, i.e., 
cytotoxicity, antiviral activity, and the enhancement/inhibition of bacterial growth, of this 
polysaccharide are still to be unveiled, in food industy ulvan represent a dietary fiber not 
degraded by human digestive enzymes, and it can be considered a potential new 
nutraceutical [Bobin-Dubigeon 1997]. Another particular interesting feature of Ulvan is 
its ability to form gels. McKinnel and Percival [1962] were first to mention the formation 
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of a stiff gel on concentrating Ulvan extract. Later on, Haug [1976] discovered that boric 
acid, calcium ions, and pH between 7.5-8.0 were required to form weak gel with Ulvan. 
The use of high ions concentration than 15-33 and ~7mM respectively, lower or higher 
pH, or Tris and phosphate buffering ions were detrimental to gel. Ulvan in the sodium 
form does not form a gel in addition of boric acid at pH 7.5 confirming that calcium or a 
divalent cation is required for gelation [Lahaye 1996] such as Cu, Zn, Mn Ca. The 
mechanism of gel formation is not understood. Haug [1972] proposed that very few 
borate esters are formed with cis-diol functions of unsulfated rhamnose residues to cross-
link Ulvan chains (Figure 1.13). Calcium ions would bridge complexes and/or stabilize 
the borate esters. Sulfate and carboxylic acid groups were later on proposed to coordinate 
to Ca (II) and participate to the gel formation. Since the gel is thermoreversible and does 
not show thermal hystereis, the interchain “junction zones” in ulvan gel are reversible and 
involve weak linkages. Thus, direct ulvan cross-links by borate esters are unlikely 
[Lahaye 2007].  
 
                                    A                    B 
 
Figure 1.13 - Proposed borate and calcium interactions in the establishment of zones leading to 
Ulvan gel. 
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The unique gelling properties, not completely clear, of Ulvan offer potential applications 
where texiture need to be precisely controlled by cations, pH, or temperature. It could be 
used to design gels able to realease entrapped molecules/particles under specific physyco-
chemical conditions [Lahaye 2007] and its strong similarities with the mammalian 
glycosaminoglycans  [Kaeffer 1999] make them interesting materials. 
 
 
1.7. CELLS ENCAPSULATION 
The construction of biomimetic microenvironments with specific chemical and physical 
cues for the organization and modulation of a variety of cell populations is of key 
importance in tissue engineering [Green 2005]. Cell encapsulation is one of the most 
promising approaches for the continuous delivery of therapeutic agents. This technology 
is based on the entrapment of cells within a polymeric matrix surrounded by a semi-
permeable membrane. This membrane isolates the encapsulated cells from the host 
immune system while allowing exchange of nutrients and waste and release the 
therapeutic agents. The selective capsule environment is able to support cellular 
metabolism, proliferation, differentiation and cellular morphogenesis, also isolate the 
cells from an outside environment. The mass transport properties of an encapsulation 
membrane are critical since the influx rate of molecules essential for cell survival and the 
outflow rate of metabolic requirements of various cell types are different and, hence, 
optimal membrane permeability is expected to depend on the choice of cells. Besides 
permeability, an important consideration is the availability of an extracellular matrix 
(ECM) to encapsulated cell [Zielinski 1994, Babensee 1992], especially for enchorage-
dependent cells. The EMC not only allows the cells to express their differentiated 
functions but also for optimal viability [Zielinski 1994, Babensee 1992].  The 
encapsulation of tissue cell within a protective microcapsule has been then explored by 
several investigators [Lim 1980, Sawhney 1993] to preclude the problems of immune 
rejection associated with the transplantation of xenogenic or allogenic tissue. Capsule 
biocompatibility is critical when encapsulated cells are intended for transplantation since 
it is the compatibility of a biomaterial with the host that ultimately determines the nature 
of host response and graft survival. The physicochemical nature of biomaterial is 
important to enhance the capsule biocompatibility and exploration of different materials 
for this purpose has necessitated development of different encapsulation procedures to 
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accommodate the varying physico-chemical properties. Capsule in the 0.3-1.5 mm range 
have been traditionally referred to as microcapsules in the cell encapsulation field. Their 
relatively small size (i.e., large surface area to volume ratio) is considered advantageous 
from a mass transport perspective [Uludag 2000].  To design an efficient drug delivey 
system that is based upon the mammalian cell encapsulation, it is essential to optimize 
and characterize different parameters associated with the system concurrently with 
parameters associated with the encapsulated cells. The viability of the cells is crucial for 
the long-term production of the desired therapeutic factor. On the other hand, it is of great 
importance for long term efficacy of the system to achieve strong and stable 
microcapsules, which will remain intact during the entire period of transplantation 
[Baruch 2005]. Microcapsules are almost exclusively produced from hydrogels since they 
hold a number of appealing features. Firstly, the mechanical or frictional irritation to 
surrounding tissue is reduced by the soft and pliable features of the gel. Secondary, as the 
consequence of the hydrophilic properties of the material, there is virtually no interfacial 
tension with surrounding fluids and tissues which minimizes the protein adsorption and 
cell adhesion. Combinations of these two factors results in a high biocompatibility. 
Thirdly, hydrogels provide a high degree of permeability for low-molecular-mass 
nutrients and metabolites. Interaction of oppositely charged polymers is the simpler way 
to form a physical membrane barrier around living cells. Being soluble in water, charged 
polymers offer the feasibility of developing an aqueous encapsulation systems that is 
compatible with cellular milieu [Uludag 2000]. Both natural and synthetic polymers were 
utilized for this purpose. Among the naturally derived polymers, alginate represent the 
common material to use in the form of microparticles. 
 
1.7.1. Alginate for Cell Encapsulation 
Due to their intrinsic properties of alginate calcium gels (biocompatibility, porosity, and 
ease of manipulation) much attention has recently been focused on cell encapsulation. For 
cell encapsulation, cell are usually suspended in a sodium alginate solution. The 
suspension is then dripped into a calcium chloride bath. Upon contact, calcium ions 
instantly crosslink with the alginate droplet to form gel beads encapsulating cells. The 
advantages of using alginate is that the capsules are formed under very mild conditions 
[Kuo 2001].  
The alginate based beads system offers advantages for the encapsulation of mammalian 
cells. The remarkable long-term mechanical properties provided by alginate outer 
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membrane and the achieved long-term viability of cells are of great advantage to consider 
this system for in vivo cell based therapy. This material has been largely investigated for 
hepatic derived cell lineage culture with purpose of regenerative medicine and in the 
present work used for hepatobastoma cell line (HepG2) encapsulation in order to evaluate 
their potential as suitable systems for  liver tissue engineering applications.  
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AIM OF THE WORK 
 
The present PhD work is part of a long-standing research activity regarding the design 
and synthesis of polymeric materials for application in Regenerative Medicine that has 
been carried out by chemists, biologists, pharmaceutical technologists, engineers and 
computer scientists constituting the research group active at the Laboratory of Polymeric 
Materials for Biomedical and Environmental Applications of the Department of 
Chemistry and Industrial Chemistry of the University of Pisa [Chiellini 2006, 1995, 
1992b; Solaro 2003, 1997; Signori 2003; Bizzarri 2002a, 1999].This study was developed 
in the framework of two research projects, one founded by European Community, 
BIOPAL QLK-CT-2002-02431 and a project performed within the framework of INSTM 
founded project PRISMA 2004. The direct collaboration with industrial and academic 
national and international partners as well as a six month stage at Chalmers University of 
Technology (Göteborg, Sweden) were part of the activities promoted by the European 
network of excellence “Expertissues”, “Network of Excellence on Novel Therapeutic 
Strategies for Tissue Engineering of Bone and Cartilage Using Second Generation 
Biomimetic Scaffolds”. 
During the last two decades, significant advances have been made in the development of 
biocompatible and biodegradable materials for biomedical applications. In the biomedical 
field, the goal is to develop and characterize artificial materials able to restore, and 
improve physiologic functions, and enhance survival and quality of life. The rapid 
expanding knowledge of new bioactive polymers obtained from low cost source such as 
polysaccharides, led many researchers to investigate the characteristics of many naturally 
derived materials. Among these, recently, particular interest has been focused on Ulvan, a 
new alginic material derived from Green algae (Ulva armoricana). The original physico-
chemical, and biological properties of this polysaccharide open the way for potential 
biomedical applications. The objective of the present work is the design, preparation and 
biological characterization of bioactive polymeric scaffolds for hepatic tissue engineering 
application. In particular attention will be focused on the preparation of scaffolds based 
on natural polymers to be combined with micro/nanoparticles containing tissue specific 
growth factor and/or cells. In a first instance scaffolds will be prepared starting from 
commercial alginate to use as reference material and subsequent trials will be aimed to 
the Ulvan based scaffolds and beads preparation All the prepared samples will be 
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carefully the investigation of swelling degree, pore size and morphology (Scanning 
Electron Microscopy) and particles will be characterized from a dimensional (Coulter 
Counter) and morphological point of view.  
The cytocompatibility and suitability of the prepared scaffolds/beads to support cell 
adhesion and proliferation will be evaluated with different cell lines such as 3T3 clone 
A31 (mouse embryo fibroblast), HepG2 (Human Hepatoblastoma). 
In vitro biological assays will be devoted to the evaluation of cell viability and 
cytocompatibility by mean of Tetrazolium Salts and Neutral Red Up-take. A careful 
morphological characterization will be performed by optical microscopy. A further aspect 
that will be investigated concerns the chemical and physical characterization of Ulvan. 
The heterogeneous structure of this polymers will be careful investigated for its content in 
neutral sugar, uronic acid and sulphate contents. Careful investigation will also be aimed 
at the investigation of surface composition, molecular weight, and thermal stability in 
order to understand the real potential of this new polysaccharide. 
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3. EXPERIMENTAL PART 
3.1. MATERIALS 
The commercial products were used as received without further purification. 
 
3.1.1. Solvents 
3.1.1.1. Acetic acid 
The commercial product (Mallinckrodt Backer) was used as received. 
 
3.1.1.2. Deionized water 
Type III laboratory grade pure water was obtained from ELIX/RiOs Pretreatment Pack 
(Millipore) equipped with PROGARD 02
TM
 with vent filter (Millipore). 
 
3.1.1.3. N,N-Dimethylformamide (DMF) 
The commercial product (Sigma) was used as received. 
 
3.1.1.4. 1-4-Dioxane 
The commercial product (Carlo Erba) was used as received. 
 
3.1.1.5. Polydimethylsiloxane silanol terminated (DMS-S31) 
The commercial product (ABCR) was used as received. 
 
3.1.1.6. Trifluoroacetic acid (TFA) 99%  
The 1M solution was prepared by adding 1.88 ml of TFA to 23.12 ml of deionized water 
 
3.1.1.7. Sulfuric acid 72% 
The solution was prepared adding 100ml of sulphuric acid to 61ml of water. 
 
 
3.1.2. Reagents   
3.1.2.1. Minisart filters 
Minisart syringe filters (porous size: 0.2 µm, 0.45 µm, 1.2 µm) in cellulose acetate 
membranes were purchased from Sartorius. 
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3.1.2.2. Metallic needles 
2 cm metal hub needles 21G of 0.8 mm of diameter were purchased from Terumo. 
 
3.1.2.3. Physiological solution 
The 0.9% NaCl solution was prepared by dissolving 9.0 g of NaCl (Carlo Erba) in 1L of 
distilled water. The solution was sterilized in autoclave for 20 min at 121°C before use 
and storage. 
 
3.1.2.4. Calcium chloride solution 
0.4% calcium chloride solution was prepared by dissolving 4.0 g CaCl2 (Carlo Erba) in 1L 
of distilled water. 
 
3.1.2.5. 0.4%Calcium chloride and 1% boric acid solution  
The solution was prepared dissolving 0.8 g CaCl2 and 2 g of H3BO3 (Carlo Erba) in 200 
ml of distilled water. 
 
3.1.2.6.  0.1N NaOH solution 
The solution was prepared by dissolving 2.0 g of sodium hydroxide in pellets (Carlo 
Erba) in 500 ml of deionised water. 
 
3.1.2.7. Phosphate Buffer Saline (10X) (PBS1) 
PBS 10X (0.1M) was prepared by dissolving 2.0 g of KCl, 2g KH2PO4·H20, 80 g of 
NaCl, and 15,6 g of NaH2PO4·12H2O in 1 L of distilled water. The pH was adjusted to 
7.2 with 10 N NaOH and resulting solution sterilized (121°C for 20 min) before use and 
storage. 
 
3.1.2.8. Tris-EDTA buffer solution 
100 ml of Tris-EDTA solution was prepared by dissolving 0.120 g of Trizma buffer (Bio 
Chemika) and 0.036 g of EDTA (Sigma) in distilled water. 
 
3.1.2.9. Ulvan I 
Ulvan I batch in flakes was kindly provided by CEVA within the framework of the EC 




3.1.2.10. Ulvan II  
Ulvan II batch in powder was kindly provided by CEVA within the framework of the EC 
funded project BIOPAL. 
 
3.1.2.11. Ulvan Ultra Purified (U.P.) 
Ultra purified Ulvan batch in laminae was kindly provided by CEVA within the 
framework of the EC funded project BIOPAL. 
 
3.1.2.12. Ulvan Not Purified (N.P.)  
Not purified Ulvan batch in powder was kindly provided by CEVA within the framework 
of the EC funded project BIOPAL. 
 
3.1.2.13. Xylan from birhwood 
The commercial product (Sigma-100G) was used as received.  
 
3.1.2.14. VT-Xylan 2000 
VT-Xylan 2000 ultra purified extracted was kindly provided by Chalmer University 
(Goteborg, Sweden).   
 
3.1.2.15. Poly(ethylene glycol) diglycidyl ether (PEGDE) Mw 526 
The commercial product (Aldrich) was used as received. 
 
3.1.2.16. Poly(ethylene glycol) diglycidyl ether (PEGDE) Mw 3496 
The commercial product (Aldrich) was used as received. 
 
3.1.2.17. Dimethyl 3-3 dithio-propionimidate dihydro chloride (DTBP) 
The commercial product (Sigma) was used as received. 
 
3.1.2.18. L-Rhamnose 
The commercial product (Sigma) was used as received. 
 
3.1.2.19. D-Glucuronic Acid 98% 
The commercial product (Aldrich) was used as received. 
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3.1.2.20. Potassium bromide 
The commercial product (IR grade 99+%, Acrōs organics) was used as received. 
 
3.1.2.21. 1-Methylimidazol 
The commercial product (Fluka) was used as received. 
 
3.1.2.22. 3-hydroxybiphenyl 
The commercial product (Fluka) was used as received. 
 
 
3.1.3. Cell Culture Materials 
3.1.3.1. Cell lines 
The Balb/3T3 Clone A31 (ATCC CCL 163) mouse embryo fibroblast cell line was 
purchased from ATCC (American Tissue Culture Collection) and propagated following 
the instruction provided by the supplier. 
The Human hepatoblastoma cell line HepG2 (ATCC HB 8065) was purchased from 
ATCC (American Tissue Culture Collection) and propagated following the instruction 
provided by the supplier. 
 
3.1.3.2. Antibiotics 
The commercial product (ATCC), a water solution containing 10.000 I.U./ml of Penicillin 
and 10.000 µg/ml of streptomycin was stored in sterile aliquots at -20°C. 
 
3.1.3.3. L-Glutamine 
The commercial product (Gibco,200 mM water solution) was stored in sterile 5 ml 
aliquots at -20°C. 
 
3.1.3.4. Fetal Bovine Serum (FBS) 
The commercial product (Gibco) was stored in sterile 50 ml aliquots at -20°C. 
 
3.1.3.5. Calf Serum (CS) 
The commercial product (ATCC) was stored in sterile 50 ml aliquots at -20°C. 
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3.1.3.6. Eagle’s Minimum Essential Media (EMEM) 
The complete EMEM was prepared by adding 1% streptomycin/penicillin, 2mM 
glutamine, 1% of sodium piruvate and supplemented with 10% fetal bovine serum (FBS). 
The solution was stored at 4°C. 
 
3.1.3.7. Complete Dulbecco's Modified Eagles Medium (Complete DMEM) 
The complete DMEM solution was prepared by adding penicillin (100 U/mL), 
streptomycin (100 g/mL), glutamine (4 mM), g/5mL of Plasmocin and supplemented 
with 10% calf serum (CS). The solution was kept at 4 °C in the dark. 
 





The commercial product (Gibco) 0.01M pH 7.4 was stored at 4°C. 
 
3.1.3.9.Trypsin-EDTA 
The commercial buffer solution (Gibco) containing 0.25% trypsin was stored in sterile 
5ml aliquots at -20°C. 
 
3.1.3.10. Trypan blue 
The commercial product (Sigma), a 0.4% water solution of trypan blue was stored at 4 C. 
 
3.1.3.11. Cell proliferation reagent (WST-1) 
The commercial product (Roche Molecular Biochemicals) was stored at -20°C in the dark 
and used according to the procedure indicated by the producer. 
 
3.1.3.12. Neutral red 
The commercial product (Sigma) was stored at 4 °C and used according to the procedure 
indicated by the producer. 
 
3.1.3.13. Disposable sterile plastic ware 
Commercial tissue culture flasks, multiwell plates, cryotubes, pipettes, syringes, and 
sterile filters were purchased from Corning Costar and Greiner Labortechnik and were 
disposed after single use. 
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3.1.4. Instrumental Characterizations 
3.1.4.1. Autoclave  
Steam sterilization of biological materials and solutions was performed in Alpha Junior 
autoclave (Pbi International) at 121°C for 20 minutes. 
 
3.1.4.2. CO2 Incubator 
Cell culture were performed in Hera Cell (Heraeus Instruments S.p.A.) CO2 Incubator in 
5% CO2 enriched atmosphere. 
 
3.1.4.3. Differential Scanning Calorimetry (DSC) 
DSC analyses were performed under nitrogen atmosphere on 5–10 mg samples by Mettler 
TA 4000 calorimeter. Glass transition temperatures were measured from the inflection 
point in the second heating cycle thermograms. Indium and gallium were used as 
calibration standards. 
 
3.1.4.4. Freeze-drying  
Lyophilised samples were dried in 5 Pascal Lio 5P lyophilisator, equipped with rV8 
(Edwards) vacuum pump. 
 
3.1.4.5. UV–Vis spectroscopy 
Absorption measurements were performed by Jasco V–530 and UNICAM UV 500 
ThermoSpectronic spectrophotometers. 
 
3.1.4.6. Absorbance measurements on microplates 
Microplate absorbance measurements were performed by means of Benchmark Bio-Rad 
Microplate Reader. All data were processed by using Microplate Manager III (Biorad) 
and Igor Pro (Wave-matrics). 
 
3.1.4.7. Infrared spectroscopy (IR) 
IR spectra were recorded on KBr pellets by using Jasco FT–IR 410 spectrophotometer. 
 
3.1.4.8. Optical Microscopy (OM) 





3.1.4.9. Scanning Electron Microscopy (SEM) 
SEM analyses were performed on lyophilized samples by JEOL LSM5600LV scanning 
electron microscopy. 
 
3.1.4.10. Refrigerate centrifuge 
Cell recovering were performed in ALC® PK 121R centrifuged, equipped with AM-10 
and AM-21 rotors. 
 
3.1.4.11. Particle size analysis 
Dimensional analyses were carried out by using a Coulter LS230 Laser Diffraction 
Particle Size Analyzer, equipped with small volume module plus. Samples were added 
into the cell until 40–50% obscuration of PIDS detector. 
 
3.1.4.12. Laminar flow cabinet 
Eperiments that required sterile conditions were performed under a Hera Safe HS12 
Bioclass II (Heraeus Instruments S.p.A.) laminar flow cabinet. 
 
3.1.4.13. Gas Chromatography (GC) 
GC analyses were performed in the 150–270 °C range by Perkin Elmer Autosystem 
instrument equipped with FID detector and either J. W. Scientific DB–5MS capillary 
column (30 meters, ID 0.32 mm, film thickness 0.1 m) or J. W. Scientific DB–FFAP 
(15 m, 0.53 mm) capillary column. 
 
3.1.4.14. Thermal Gravimetric Analysis (TGA) 
TGA measurements were carried out on 10–12 mg samples in the 25–800 °C or 25–
600 °C range under nitrogen atmosphere at 10 °C/min heating rate by a 
Thermogravimetric Analyzer TGA Q500. 
 
3.1.4.15. Nuclear Magnetic Resonance (NMR) 
NMR spectra were recordered on Bruker DRX-400 spectrometer operating at 400 MHz 
for proton observation.  Spectra were processed by using MacFID 1D 5.3 (Tecmag Inc.) 
software. 
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3.1.4.16. pH measurements 
Measurements were performed by Hanna Instruments pH 211 and IQ Scientific 
Instruments IQ150 pH–meters calibrated with two standard buffer solutions having pH 
4.01 and 7.01, respectively. 
 
3.1.4.16. Viscometry 
Viscosity measurements were carried out at 25 °C on four different batches of Ulvan by 
Viscodoser AVS20 (SCHOTT) viscometer. Solutions were prepared by dilution of a 
solution containing a weighed amount of polymer in a known deionized water volume. 
Concentrations were calculated by assuming the same density for pure solvent and 
polymer solution at the measurement temperature. Efflux times of the solvent (t0) and of 
the solutions (t) were measured, and specific viscosity (ηsp = t-t0/ t0) was computed. 
Intrinsic viscosity [η] values were determined by extrapolating ηsp/c for c → 0. 
 
3.1.4.17. Size Exclusion Chromatography (SEC) 
SEC equipment consisting of a Waters 2690 with online degasser, autosampler and 
column oven (waters Milford, MA, USA) and two serially connected colums controlled at 
50°C (TSK gel G6000 WXL and TSK gel GMPWXL, TosoHaas, Stutgart, Germany). 
The detector used was a multi angle light scattering (MALLS), Dawn DSP equipped with 
a light source of He-Ne laser at 632.8 nm, Wyatt Technology Corp.) and UV-monitor set 
to record at 280 nm (Shimadzu SPD-10A, Shimadzu Corp., Kyoto, Japan). Data for 
molecular weight distribution was analyzed using a ASTRA software (version 4.73.03. 




3.2.1 Raw Material Characterization  





3.2.1.1. Sugar composition 
The sugar determination of Ulvan was optimized by acid hydrolysis. The different 
constitutive sugars, released after hydrolysis, were reduced and analyzed as alditol 
acetates by gas chromatography (GC). 
 
3.2.1.1.1. Hydrolysis 
200 mg of Ulvan was weighted into a 200 ml beaker  and 3 ml of 72% sulfuric acid 
(H2SO4) 12M  were added. The sample, completely covered by the acid, was dispersed 
for a few minutes with a round-melted glass rod and then placed in a desiccator under 
vacuum for 15 min. The beaker with rod was shaken automatically in a water bath for 1 
hour at 30°C.  Next, deionized water (84 mL) was added and the beaker covered with 
aluminium sheet. The beaker was put in a preheated autoclave for 1 hour at 125°C. While 
the resulting hydrolysis mixture was still warm, the insoluble material was quantatively 
filtered using a filter of 0.22 µm, and thoroughly washed with distilled water (3x 5mL). 
The filter was dried (105°C, 18 h) and the filtered material determined gravimetrically. 
The filtrate, after cooling down, was collected and transferred to a volumetric flask  and 
adjusted with deionised water to 100 mL. 5mL of the solution was added to a 50 mL 
volumetric flask along with 5 mL of internal standard, 2- deoxy- D-Galactose and L-
Rhamnose (10µl/mL), and the volume was adjusted with deionised water. The main part 
was reduced with KBH4 and then acetylated with acetic anhydride/pyridine.  
 
3.2.1.1.2. Reduction and acetylation 
A part of hydrosylate (1 mL) was made alkaline in a test tube with 100µl of 12 M 
ammonium hydroxide and then reduced at 40°C for 1 hour in a thermostated water bath 
with 3M acqueous ammonium hydroxide (100µl) cointaining potassium borohydride (15 
mg). After addition of glacial acetic acid (100 µl), parts (0.5 mL) of the resulting solution 
were mixed with 1-methylimidazole (0.5 mL) and acetic anhydride (5 mL) and allowed to 
react for 10 min. Absolute ethanol (1mL) was added next, and after 10 min the tube was 
placed in a water bath at room temperature. Water (5 mL)  was added and followed by 
duplicate portions (5 mL) of 0.75 M potassium hydroxide with a few minutes interval. 
The tubes were vibromixed and left for 10 min, and the formed upper layer was 
transferred to a vial containing a small amount of anhydrous sodium sulphate. The 
resulting alditol acetates were quantified by Gas Chromatography (GC). The column was 
a fused silica of 30 m x 0.25 mm x 0.2 dimensions micron (thickness) and the software 
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used for analysis was Star Varian version 5.52. N2 was used as bearing gas and the flow 
rate was 1.15 ml/min. Detector temperature was 230 degrees and the oven temperature 
was initial 150 and final 250 degrees. Heating rate was 15 degrees /min, 10 min to heat up 
and reach the final temperature (250 degrees), held for 16.6 min. Hydrolysis was also 
performed with Trifluoracetic acid (TFA) 1M for a comparative study. 
 
3.2.1.2. Uronic acid detection 
For quantitative determination of uronic acid in Ulvan backbone, 2 ml of the sample, 
dissolved in deionized water, containing from 0.5 to 0.2 µg of uronic acids was added to 
1.2 ml of sulphuric acid/tetraborate. The mixture was refrigerated in crushed ice, shaken 
in a Vortex mixer and then heated in a water bath at 100°C for 5 min. After cooling in a 
water-ice bath, 20 µl of the 3-hydroxymetabiphenyl reagent was added. Finally the 
sample was shaken and, within 5 min, absorbance measured at 520 nm in a PERKIN 
ELMER Lambda 20 spectrophotometer. NaOH 0.5% was used as blank and its 
absorbance was subtracted from the total absorbance. Calibration curve, used as reference 




Figure 3.1 - Calibration curve used as reference for the detection Uronic acid. 
 
 
3.2.1.3. Elementary analysis 
Elementary analysis was carried out in the laboratories of MIKRO KEMI AB, Uppsala 
Stockholm (Sweden) in order to evaluate the C, H, N and S content. The protein 
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percentage was calculated from the nitrogen content performed according to the Kjedhal 
method. 
 
3.2.1.4. Molecular weight determination  
Size exclusion chromatography (SEC) analysis of Ulvan samples were performed  
dissolving 10 mg of Uvan (2 mg/ml) in 5 ml MilliQ water and maintained under stirring 
overnight. The samples were filtered (0.45 µm) and 1 ml was injected and analyzed with 
HPSEC-UV-MALLS-RI system. The mobile phase was 0.1M NaNO3 containing 0.01% 
NaN3, with flow of 0.4 ml/min. 
 
3.2.1.5. Surface analysis 
The surface chemical composition of Ulvan was determined by Electron Spectroscopy for 
Chemical Analisys (ESCA). A Quantum 2000 from Physical Electronics with 
monochromatic Al Ka as the X-ray source was used for the measurements. The area 
analysed was 500x500 µm and beam size was 100 µm. The angle between the sample and 
detector was 45°C. The information depth of the samples is approximately 4-5 nm. The 
peak intensities and curve fitting were done using MultiPak 6.1 a software from Physical 
Electronics. A neutralizer was used to avoid charging of the surface. 
 
3.2.1.6. Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) measurements were performed by using a 
Mettler DSC-822. The sample of 10-15 mg were weighted in 40 µl aluminium pan and an 
empty pan used as reference. Measurements on Ulvan II were carried out under 80ml·min
-
1
nitrogen flow rate according to the following protocol: 
 
-First cooling from 25°C to -50°C at 10°C/min followed by a 3 minutes isotherm at -
50°C. 
-First heating from -50°C to 230°C at 10°C/min 
- Second cooling (quenching) from 230°C to -50°C at -20°C/min  
-Second heating from -50°C to 230°C at 10°C/min 
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3.2.1.7. Thermogravimetric analysis (TGA) 
A TA Thermogravimetric Analyzer TGA Q500 was employed for TGA analysis. 
Evaluations were performed on 10-20 mg samples at 10°C/min under a 60 ml/min gas 
flow. The Ulvan II samples were analyzed by varying the temperature from 25°C to 
600°C under nitrogen and air flow. 
Ulvan II 
- From 25°C to 600°C under nitrogen and air flow. 
 
A Mettler Thermogravimetric Analyzer TA 400 equipped with a Mettler TG50 furnace, a 
Mettler M3 microbalance and a TA72 GraphWare software was employed for TGA 
analysis UlvanII. Evaluations were performed on about 10 mg samples from 25°C to 
600°C at 10°C/min under 60ml/min air flow. Analysis were performed both on raw and 
dried samples.  
 
3.2.1.8. Solubility 
Solubility of Ulvan was tested by dissolving 100 mg/ml of sample in chemical solvents 
such as in N,N-Dimethylformamide (DMF), 1-4-Dioxane, Polydimethylsiloxane silanol 
terminated and trifluoracetic acid (TFA). 
 
3.2.1.9. Spectra analysis 
Infrared spectrum was recorded from Ulvans powders in KBr pellets on a Jasco FT-IR 
410 spectrophotometer.  
 
3.3 SCAFFOLDS PREPARATION 
Alginate and Ulvan based scaffolds were prepared following two different strategies 
using physical crosslinking agents both for commercial Alginate and Ulvan and chemical 
crosslinker specifically for Ulvan. 
 
3.3.1. Physically Crosslinked Scaffolds 
Calcium chloride (CaCl2), boric acid (H3BO3) and Dimethyl 3-3 dithio-propionimidate 
dihydro chloride (DTBP) were used both with commercial alginate and Ulvan as physical 





3.3.1.1. Commercial alginate based scaffolds 
0.8 g commercial sodium alginate, low viscosity, was dissolved in 40 ml of physiological 
saline solution (0.9%NaCl) at room temperature (RT). The Alginate solution was 
crosslinked with calcium ions by adding an equal volume of 0.4% (0.16 g) of CaCl2 
solution (1.44 mmoli), while stirring intensively, to obtain a smooth 2% w/v alginate 
solution. The solution then was homogenized with Ultra Turrax T18 Basic (IKA) and 
placed into a 12-well polystyrene plate (2ml/well), frozen at-20°C overnight and finally 
the ice crystals were removed by sublimation. 
 
3.3.1.2. Ulvan based scaffolds 
Four types of Ulvan, called Ulvan I, Ulvan II, Ulvan Ultra Purified (U.P.) and Ulvan Not 
Purified (N.P.), kindly provided from CEVA within the framework of the EC funded 
project BIOPAL, were used for scaffolds preparation. All processes were carried out at 
room temperature (RT). For scaffolds preparation, 0.4 g of Ulvan was dissolved in 
physiological solution (20ml) to a final concentration of 2% w/v. The polymer was 
crosslinked by mixing an equal volume of a solution containing 0.4% (0.0800g) of CaCl2 
(0.72mmoles) and 0.5% (0.1 g) of H3BO3 (1.62 mmoles) or H3BO3 and DTBP under 
constant vigorous stirring. The solution was then homogenized, placed in 12-well 
polystyrene plate and finally freeze-dried as previously described. In futher scaffolds 
preparation growing concentration of H3BO3 (0.5%, 1%, 1.5%, 3%, 5%) was used in 
order to have comparative results. The concentration of calcium chloride was maintained 
unvaried (0.4%). 
 
3.3.1.3. Ulvan II based scaffolds crosslinked with Dimethyl 3-3 dithio-propionimidate 
dihydro chloride (DTBP) 
0.6 g of Ulvan II was dissolved in 15 ml of PBS pH7 at final concentration of 2% w/v and 
crosslinked by adding an equal volume of DTBP (3 mg) 2% w/w (0.010 mmoles), while 
stirring intensively. The obtained well homogenized solution was then placed in 12-well 
polystyrene plate, and scaffolds were obtained by freeze-dry technique. In subsequent 
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Table 3.1: Ulvan II chemically crosslinked with PEGDE. Vf 30 ml.  
 Polymer Solvent Crosslinking agent 
 Ulvan II PBS pH 7 DTBP 
 Ulvan II PBS pH 7 DTBP, H3BO3 
 Ulvan II PBS pH 9 DTBP 
 Ulvan II PBS pH 9 DTBP, H3BO3 
 Ulvan II                         Physiological solution DTBP 
 Uvan II                          Physiological solution DTBP, H3BO3 
 Ulvan II Tris-EDTA DTBP 
 Ulvan II  Tris-EDTA DTBP, H3BO3 
   
3.3.2. Chemically Crosslinked Scaffolds 
Two different type of PEGDE with different molecular weight, Mw, (526 and 3496) were 
used in chemically crosslinked scaffolds formulation. The crosslinking agents were added 
to Ulvan attributing to this an arbitrary Mw of 5000 Da and 50000 Da.  Typical procedure 
is described in details by following. 
 
3.3.2.1. Ulvan based scaffolds crosslinked with poly (ethylen glycol) diglycidyl ether 
(PEGDE) 
0.2 g Ulvan was dissolved in 10 ml NaOH 0.1N (pH 13) at final concentration of 2% w/v. 
PEGDE was added in an appropriate volume (36 µl) considering a crosslinking agent and 
polymer molar ratio of 2:1 The polymeric solution obtained was placed into 12-well 
polystyrene plate and then in oven at 60°C for 45 min. The plate was frozen at -20°C 
overnight and finally lyophilized until dry. In further preparation, the pH of Ulvan-
PEGDE solution was adjusted to pH 7 by adding 7 µl of acetic acid (CH3COOH) 
dropwise.  
 
Table 3.2 - Ulvan Chemically crossilnked with PEGDE; Vf 10 ml; solvent NaOH 0.1N, for Ulvan 
U.P.* was used NaOH 0.01N.  
 Polymer MwUlvan (Da)  Mw PEGDE  mmoli PEGDE 
 Ulvan II 5000  526  0.078 mmoles 
 Ulvan II 50000  526  0.02  mmoles 
 Ulvan II 5000  3496  0.05 mmoles 
 Ulvan II 50000  3496  0.005 mmoles 
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 Ulvan U.P. 5000  526  0.078 mmoles 
 Ulvan U.P.* 5000  526  0.078 mmoles 
 Ulvan U.P. 73400  526   0.005 mmoles 
 
Different concentration of NaOH and different temperature were used in PEGDE 
crosslinked scaffolds in order to obtain comparative results: 
 
Table 3.3: Ulvan II chemically crosslinked with 36 µl of PEGDE;Vf 10 ml. 
Polymer NaOH Temperature 
 Ulvan II 10% RT 
 Ulvan II 10% 75°C 
 Ulvan II 20% RT  
 Ulvan II 10% 75°C  
 
3.2.3. Ulvan /Xylan Based Scaffolds  
Two different type of Xylans, commercial and ultra purified batches, were used in 
combination with Ulvan U.P. for scaffolds preparation. A typical procedure is described 
in details by following. 
 
3.2.3.1. Ulvan /Xylan based scaffolds crosslinked with PEGDE 
0.2 g Ulvan Ultra purified (2%w/v) were blended with 4 mg (2% w/w) of Xylan U.P. 
(2.86·10-
4
 mmoles) and dissolved together in 10 ml of 0.1 N NaOH; 36 µl of PEGDE 
were added during stirring and before to place the plate in oven. Freezing and 
lyophilization were the final steps for scaffolds preparation. 
 
Table 4: Ulvan U.P. blended with Xylan and  chemically crosslinked with PEGDE. 
 Ulvan  Xylan Xylan Concentation  
  Ultra Purified    Ultra Purified   2%w/v 
  Ultra Purified   Commercial  2%w/v 
  Ultra Purified   Ultra Purified   4% w/v 
  Ultra Purified   Commercial  4% w/v 
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3.4. FORMULATION OF CELLS LOADED SCAFFOLDS 
In order to study the ability of the prepared ulvan based scaffolds to sustain cell adhesion 
and proliferation Ulvan chemically and physically crosslinked scaffolds, previously 
sterilized, were seeded with HepG2 cell line. 
 
3.4.1. Chemically Crosslinked Scaffolds Seeded with HepG2 
Ulvan II based scaffolds chemically crosslinked, with a diameter of 2 cm, a thickness of 5 
mm and pores of 100 µm in diameter, in according with SEM measurements, were used 
as support for cell growth. Approximately 1x10
6
 in 1 mL of EMEM were seeded onto 
scaffold discs placed in 6-well culture plate and placed in a incubator at 37°C 5% CO2 for 
30 min in order to allow the cells to fill up the pores of the constructs. After the complete 
absorption of liquid into the scaffolds, an additional volume, 5 ml, of warm culture 
medium was added to each well. The medium was changed after 24h the first time and 
every 2 days thereafter. The same protocol was used for ultra purified batch of Ulvan. The 
same protocol was employed with  an ultra purified batch of Ulvan. 
 
3.4.2. Physically Crosslinked Scaffolds Seeded with HepG2 
Physically crosslinked scaffolds with DTBP were also used for cell study. A concentrate 
suspension of 1 ml of culture medium (EMEM) containing 1x10
6
 cells were seeded on the 
top of dry scaffold. The scaffolds were incubated for 30 min at 37°C, followed by 
addition of fresh medium to each well, as previously described. 
 
 
3.5. ALGINATE BEADS  
Alginate, recognized as an excellent candidate material for implantation in biological 
system, was used as model material for cell encapsulation. A typical procedure is 
described in details by following. 
 
3.5.1. Naked Alginate Beads Preparation  
0.4 g of sodium alginate (2% w/v) was dissolved in 20 ml distilled water containing 0.9% 
sodium chloride. The prepared solution was added dropwise through a 21G needle from a 
plastic syringe at a rate of 10ml/h, into a beaker containing 100 ml calcium chloride 
solution (1.5% w/v) under gentle stirring. The formed particles were harden for 15min in 
CaCl2 solution and then rinsed with distilled water. 
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3.6. FORMULATION OF CELL LOADED BEADS
 
Thanks to their peculiar physico-chemical properties and their well assessed 
biocompatibility, alginates are well known materials used for cell encapsulation. A typical 
procedure for cell loaded beads is described by following. 
 
3.6.1. HepG2-loaded Beads  
100 mg of sodium alginate, sterilized under UV for 30 min, was dissolved in 5 ml 
complete EMEM in sterile condition. Approximately 1x10
6
cell contained in 200 µl of 
Eagle’s Minimum Essential Media were added to the polymeric solution.  The 
alginate/cells suspension was added dropwise, using a syringe equipped with a 21 G 
needle, in 5 ml of 1.5% calcium chloride solution contained in a 6-well sterile plate and 
maintained under magnetic stirring. Beads containing cells were washed with warm 
media and then incubated at 37°C 5% CO2. The cells medium was changed every 2 days. 
The entire process took place in sterile condition and at room temperature. 
 
 
3.7. SCAFFOLD AND ALGINATE BEADS CHARACTERISATION 
3.7.1. Swelling Degree  
Swelling degree studies of prepared scaffolds were carried out in modified Eagle’s 
Minimum Essential Media (EMEM) pH 7.4, both room temperature (RT) and 37°C. 
Previously weighted scaffolds were immersed in EMEM cell culture medium, the 
medium was carefully withdrawn at intervals and weight measured. The swelling degree 




R% = Swelling degree 
Ww = Wet weight 
Wd = Dry weight 
 
3.7.2. Scanning Electron Microscopy (SEM) 
Surface morphology of beads and three-dimensional (3-D) structure of scaffold were 
investigated by JEOL LSM 5600LV and JSMT100 (JEOL) scanning electron 
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3.7.3. Dimensional Analysis 
Dimensional analysis of microparticles were carried out by Coulter LS230 Laser 
Diffraction Particle Size Analyzer, equipped with small volume module plus. 
Microparticles suspensions were added into the cell until 30-50% odscurtion of PDS 
detector was reached. Deionised water was usedas background and diameter distribution 




3.8. IN VITRO ASSESSMENT OF CYTOTOXICITY 
3.8.1. Cell Propagation 
3.8.1.1. Cryopreservation and cell thawing 
Cells were suspended in 1 ml aliquots of fetal bovine serum (FBS) or Calf Serum (CS) 
containing 10% of DMSO. The suspensions were transferred in vials that were dry-ice 
overnight and finally stored at -80°C in liquid nitrogen. The cells were thawed, before 
use, by using the following protocol: The vial was thawed by gentle agitation in a 37°C 
water bath (approximately in 2 min).The vial content was transfer tube containing 9 ml of 
complete culture medium and centrifuged for 5 min at 1000 rpm in ALC
®
 PK 121R 
centrifuge (AM-10 rotor).The vial content was disperse in a 25 cm
2
 culture flask and 
incubated at 37°C in humidified 5% CO2 incubator. The culture medium was renewed 
24h after seeding. 
 
3.8.1.2. Cell counting by dye–exclusion hemocytometry 
The hemocytometer is a microscope slide with grids on it to give nine large squares 
divided by triple lines. Each large square has 1 mm
2
 area. The depth of fluid in the 






One drop of 0.2 mL cell suspension in 0.3 mL of PBS2 and 0.5 mL of 0.4% trypan blue, 
resulting in a 1:5 dilution (D), was placed in the hemocytometer chamber. The chamber 
was placed on the stage of an inverted optical microscope and all cells excluding trypan 
blue (the dye penetrates non–viable cells that appear blue) present in the five large 
squares were counted, N being the number of the counted cells. The number of viable 










Figure 3.2 - Schematic representation of  hemocytometer. 
 
 
3.8.1.3. Subculturing of continuous cell lines grown in monolayers 
A 25 mL flask containing exponentially growing cells was observed in an inverted 
microscope to evaluate the level of cell confluence. The complete DMEM medium was 
then removed and cells were rinsed for a few minutes with PBS2. The buffer solution was 
then removed and cells were incubated with 0.4 mL of trypsin/EDTA solution at 37 °C in 
5% CO2 incubator for 5 minutes or until the monolayer started to detach from the flask. 
Cells were suspended in 10 mL of complete DMEM medium and then centrifuged at 
1000 rpm for 5 minutes. The pellet was suspended in an appropriate volume of DMEM 
and plated in a 25 mL flask at a split ratio of 1:6, 1:12, and 1:15. 
 
 
3.8.2 Sample Preparation 
Cytotoxicity of polysaccharides was investigated by assessing the viability of 3T3/A31 
fibroblasts grown in complete DMEM medium containing the test materials dissolved at 
different concentrations. The quantitative analyses of cell viability were performed by 
WST–1 and Neutral Red assays. 
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3.8.2.1. Preparation of polymer solution 
Stock polymer solutions were prepared by dissolving 100 mg of polymer in 10 mL of 
complete DMEM in sterile condition. The pH of the resulting solutions was adjusted to 
7.2–7.3 with 10 N NaOH before to use in combination with 3T3/A31 cell line. Beads 
sample were prepared as described in § 3.5.1. 
 
3.8.3. Quantitative Evaluation of Cytoxicity 
A subconfluent monolayer of 3T3/A31 fibroblasts was trypsinized using a 0.25% trypsin–
1mM EDTA solution. Cells were centrifugated at 1000 rpm for 5 minutes, re-dispersed in 
complete DMEM medium and counted. Appropriate dilutions were made in order to 
obtain 3 x 10
3 
cells per 100 ml of medium, the final volume present in each well of flat–
bottom 96–microwell plates. Plates were incubated at 37 °C, 5% CO2 for 24 hours until 
60–70% cell confluence was reached. The medium from each well was then removed and 
replaced with fresh medium containing different concentration of the material under 
investigation (Figure 3.3, columns 1-10). Control cells (column 11) were incubated with 
fresh growth medium, whereas wells containing only growth medium were used as blank 
(column 12). 
 





Figure 3.3 - Schematic representation of 96 well cell culture plate used for cytotoxicity 
tests. 
 
3.8.3.1. WST–1 cell proliferation assay 
After 24 h incubation in polymer containing medium, cells were incubated with WST–1 
Cell Proliferation Reagent diluted 1:10 (as indicated by the manufacturer) for 4 h at 37 
°C, 5% CO2. Plates were then analyzed with a Bio–Rad Benchmark Microplate Reader. 
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The number of viable cells was evaluated from the sample absorbance at 450 nm 
diminished by the blank absorbance at the same wavelength and by using 620 nm as 
reference wavelength. 
 
3.8.3.2. Neutral red cell proliferation assay 
After 24 h incubation in polymer containing medium, cells were incubated with Neutral 
Red diluted 1:10 (as indicated by the manufacturer) for 2 h at 37 °C, 5% CO2. The 
medium containing the vital dye was then removed and cells were briefly washed with 
PBS2. The incorporated dye was then released from the cells by washing with 1:50:40 by 
volume acetic acid:ethanol:water mixture. The number of viable cells was evaluated 
spectrophotometrically measuring the absorbance at 540 nm diminished by the blank 
absorbance at the same wavelength (reference wavelength: 620 nm).The neutral red 
solution was filtered, with a filter of 0.2µm, before use. 
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4. RESULTS AND DISCUSSION 
Polymers are applied for a large number of medical applications: as medical devices, 
support or replacement of malfunctioning body parts or as a drug reservoir providing a 
local therapeutic effect. The specifications for the selected material strongly depend on 
the application. For temporary applications, biodegradable polymers may be the preferred 
candidate. In the past 3 decades, a large range of biodegradable polymers have been 
developed, tested and applied for a wide variety of medical applications [Schacht 2003]. 
It appears clear that the design of new materials with optimal biological, chemical and 
physical properties is a challenge for Regenerative medicine. Novel materials are 
typically developed using a trial and error approach, which is costly and time consuming 
[Camarda 1999]. Study devoted to exploit the potential of new materials decrease 
considerably the time and effort required to improve material properties in terms of their 
efficacy or to discover new materials with desired properties.  
Although during the last decades, significant advances have been made in the 
development of biocompatible and biodegradable polymers, the goal the biomedical field 
is to develop and characterize natural material for use in the human body to measure, 
restore and improve physiologic function, and enhance survival and quality of life. 
Differently from synthetic polymers, that were extensively used for medical use adapting 
their microstructures to provide a desired response in the human body, polysaccharides 
interact in a favourable way with biological environment and are of particular interest in 
joint-related repairs based on their similarity to glycosaminoglycans in mammalian 
extracellular matrices.  Polysaccharides are abundant and readily available from 
renewable sources such as the algal and plant kingdoms, cultures of microbial selected 
strains, as well as through recombinant DNA technique. Thus, have a large variety of 
composition and properties that cannot be easily mimicked in a chemical laboratory, and 
the ease of their production makes numerous polysaccharides cheaper than synthetic 
polymers [Coviello 2007]. In general, polysaccharides-based biomaterials are functional 
polymers constituted by simple sugar monomers  The monomers (monosaccharides) are 
linked together by O-glycosidic bonds that can be made to any of the hydroxyl groups of 
a monosaccharide, conferring polysaccharides the ability to form both linear and 
branched polymers. Differences in the monosaccharide composition, chain shapes and 
molecular weight dictate their physical properties including solubility, gelation and 
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surface properties Due to their non toxic nature, biocompatibility, and number of peculiar 
physical-chemical properties these biomaterials started to be considered as an emerging 
class in several biomedical fields such as tissue regeneration, drug delivery devices and 
gel-entrapment systems for the immobilization of cells. Several advantages can be 
derived from the use of these macromolecules. First of all, probably because of the 
chemical similarities with heparin, polysaccharides show good hemocompatibility 
properties. Their excellent properties such as nontoxicity (monomer residues are not 
hazardous to health) water solubility or high swelling ability by simple chemical 
modification, stability to pH variations, and a broad variety of chemical structures, make 
polysaccharides the polymer group with the longest and widest medical application 
experience [Hon 1996, Miayamoto 1989]. This versatility makes these materials able to 
overcome some disadvantages like low mechanical, temperature and chemical stability, 
and susceptibility to microbial and enzymatic degradation, which, in some case can be 
used as an advantage [Barbosa 2005]. 
 
 
4.1. ANALYSIS OF NEUTRAL POLYSACCHARIDES CONSTITUENTS 
4.1.1. Sugar Composition 
The identification of main constituent of polysaccharides which comprise the backbone of 
polymer represent the first step to better understand  the potential application of new 
materials. The most widely applied methods for the quantification of polysaccharides 
requires to break down these polymers into monosaccharides through hydrolysis. 
Treatment with 12 M sulphuric acid indeed represent the common procedure for 
structural investigation of unknown polysaccharides. In this study, the determination of 
the chemical composition of the water-soluble polysaccharides from Ulva, referred to as 
Ulvans, appears extremely important to elucidate their fine structure and their potential 
applications in Regenerative Medicine. All investigations were carried out on four 
different batches of Ulvan all supplied by CEVA within BIOPAL European funded 
project. The four batches  showed different physical aspects such as flakes, powder, 
laminae and different degree of purity.  The samples were conventionally named Ulvan I 
(flakes), Ulvan II (powder), Ulvan U.P.(laminae) and Ulvan N.P. (powder). According to 
the literature, the sugar determination of ulvans was optimized by acid prehydrolysis by 
dispersing the samples in cold 72% sulphuric acid followed by hydrolysis steps in diluted 
acid solution in order to determinate the breaking of glucosylic bounds. Further for 
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decreasing the total time for analysis of released monosaccharides, due to eventual 
presence of water insoluble fractions, the samples were subjected to autoclaving for 1 
hour at 125°C. The resulting hydrolysis mixture was filtered and the amount of non-
hydrolysable material was dried in oven at 105°C overnight and analyzed after drying to 
constant weight. It is reasonable to assume that sulphate esters formed during the pre-
treatment with 12 M sulphuric acid are sufficiently hydrolyzed by the autoclaving 
condition used. The following step of reduction performed by using potassium 
tetrahydroborate (KBH4) determined the opening of the constituent rings of the main 
backbone, and the reduction of reducible groups, such as acid and aldehyde, in alcoholic 
groups with the formation of poliols. The subsequent analysis of monosaccharides as 
alditol acetates in the acid hydrolysate was considerably fast and simple because 1-
methylimidazole was used as catalyst for acetylation. The metylimidazole was effective 
even in the presence of borate, which is formed by borohydride reduction of sugars and 
known to retard acetylation. The subsequent quantification of the resulting alditol acetates 
and then of resulting individual sugar (glucose, xylose, mannose, galactose and others) 
were determined after derivatization by Gas Chromatography (GC) analysis performed in 
the 150-270°C range by means of a fused silica high retention column of 30m x 0.25 mm 
x 0.2 µm thickness and a N2 carrier flow (1.15 ml/min). Data obtained from all procedure 
gave valuable information on the total neutral sugar content on the composition of Ulvan 
polysaccharide, highlighting that when H2SO4 was used for hydrolysis, chromatograms 
(Figure 4.1) were clearer than those obtained on the samples hydrolyzed in TFA, probably 
due to the soft breaking of glucosylic bounds and thus there is a lower probability of 
identifying the sugar at the same position. 
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Figure 4.1 - Chromatogram of neutral sugar composition of Ulvan Ultra Purified (U.P.): 
Rhamnose, arabinose, xylose, internal standard, mannose, galactose, glucose. 
 
 
The results displayed in Table 4.1 revealed that the dominant monosaccharide, for all 
batches of Ulvan, was rhamnose that contributes from 12,9% to 17.5% of the total neutral 
sugar content. The content of other neutral sugar was relatively low, higher peaks for 
xylose and glucose from 3.9% to 8.8% and 5.6% to 10.7% respectively, were detected. 
The polysaccharides fraction also contained high amounts of ash 24.2% calculated after 3 
cycles in oven at 200°C and 400°C at 30 minutes each and then at 525°C overnight. Ash 
was attributed to counterions associated with sulphate groups and uronic acids of the 
polysaccharides and proteins may exist in the polysaccharides and sulphated 
glycoproteins [Ray 1995]. 
 
Table 4.1 - Sugar composition ad ash content of investigated baches of Ulvan. 
Neutral Sugar Ulvan I                    Ulvan II                   Ulvan U.P.                 Ulvan N.P. 
                          Composition %      Composition %        Composition %         Composition %    
Rhamnose  12.9   16.4   17.5  16.5 
Xylose   3.9   4.0   8.8  5.3 
Mannose  0.6   0.2   0.5  0.2 
Galactose  2.3   1.0   1.4  1.0 
Glucose  8.4   5.9   5.6  10.7 
Ash Content  24.21   24.21   24.21  24.21 
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4.1.2. Uronic Acid Detection 
The quantitative determination of uronic acid was performed by exploiting a new method 
based upon the appearance of a chromatogen when uronic acid heated to 100°C in 
concentrates sulphuric acid/tetraborate is treated with 3-hydroxymetabiphenyl. The 
absorbance measurements were made at 520 nm in a PERKIN ELMER Lambda 20 
spectrophotometer. Assays of pure standard of guluronic acid with this new method 
indicated that the absorbance obtained, measured following the Lambert and Beer’s law, 
is proportional to the uronic acid content. Preliminary treatment with sulphur acid at 
100°C determinate the breaking of glucosilic bounds in Ulvan structure. The presence of 
sodium tetraborate dissolved in sulfuric acid makes the carboxylic groups particularly 
reactive to metahydroxybiphenyl reagent. The high sensitivity and specificity of reagent 
used for uronic acid moiety allowed the production of pink chromatogen easily revealed 
by spectrophotometer. The data obtained from this colorimetric assay showed that the 
percentage of uronic acid is in the range of 9-11% for samples not purified and purified 
respectively as displayed in the following Table. 
 
 
Table 4.2 - Uronic Acid content. 
Sample Identity Uronic Acid % 
Ulvan I     9.32 
Ulvan II    11.56 
 Ulvan U.P.   11.46 




4.1.3. Elementary Analysis 
Elementary analyses were carried out in the laboratories of MIKRO KEMI AB, Uppsala 
Stockholm (Sweden) in order to evaluate the protein nitrogen and S content. Results 
obtained showed the presence of fairly high amount of sulphate groups bound to the 
glucosilic moieties of Ulvan and proteins, measured as nitrogen content in accord to the 
Kjedhal method (Nx6.25), and revealed a contamination in the range of 2% and 9%. The 
sulphate content was between 5% to 6.3%,  higher value were detected in ultra purified 
batch as displayed in detail in Table 4.3. 
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Table 4.3 - Elementary analysis of Ulvan batches, *protein content  calculated using the 
Kjeldahl’s number (6.25). 
Sample Identity Test Parameter Results W% Proteins %* 
Ulvan I  C  30.0     30.0  
 H  4.3       4.3 
 N  1.4       1.4  8.75 
 S  5.0       5.0 
Ulvan II C  29.3     29.3 
 H  4.3       4.4 
 N  0.5       0.5  3.1 
 S  5.9       5.9 
Ulvan U.P. C  29.3     29.0 
 H  4.6       4.6 
 N  0.6       0.5  3.75   3.1 
 S  6.3       6.3 
Ulvan N.P. C  28.5     28.5 
 H  4.2       4.2 
 N  0.4       0.4  2.25 
 S  5.7       5.8 
 
 
4.1.4. Molecular Weight Determination 
Size-exclusion chromatography (SEC), coupled with molecular weight-sensitive detector, 
is the most widely used technique for determining the molecular weight distribution 
(MWD) and average molecular weights of synthetic and natural polymers. Light-
scattering detectors are very useful since they provided absolute measurement of 
molecular weight without requiring any calibration. Beside, these detectors are very 
efficient, detecting aggregates even at low concentrations. The multiangle laser light 
scattering offers and added advantage that is the determination of the molecular 
dimension of the polymer, in terms of the radius of gyration, from the angular dependence 
of scattered light [Wyatt 1993a, Wyatt 1993b]. This combination of molecular weight and 
dimensions of the polymer chains can be used to obtain important information about size, 
shape and conformation of polymer chains in solution [Tarazona, 2003]. 
For molecular weight investigation, each batch of Ulvans was dissolved in water, at room 
temperature overnight, and adjusted to a final concentration of 2mg/ml. After filtration on 
a 0.2 µm filter the solution was submitted to SEC-UV-RI inspection. The first results 
obtained showed that the light scattering (LS) intensities for each fraction were rather 
high thus indicating the presence of aggregates. Two (Ulvan I and Ulvan II) of the four 
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samples analysed, showed SEC traces in keeping with absence of fairly low molecular 
weight fractions that were instead present in the remaining two samples (Figure 4.2). The 
weight-average (Mw) and number-average (Mn) of the analyzed samples are reported in 
Table 4.4.  
 
 A B 
 C D 
Figure 4.2 - Size exclusion chromatograms showing molecular mass distribution of samples 
dissolved in water(2mg/ml): A) Ulvan I; B) Ulvan II; C) Ulvan U.P.; D) Ulvan N.P. 
 
 
The recorded molecular weights were in the range 36-65 kDa with interestingly a fairly 




Table 4.4 - Comparison between weight-average (Mw) and number-average (Mn) 
for each batch of Ulvan investigated. 
 Sample Identity Mw(Da) Mn  Mw/M  
 Ulvan I  48710  37200  1.30 
 Ulvan II  36930  35030  1.05 
 Ulvan U.P. 65340  50810  1.28 
 Ulvan N.P.  55630  45940  1.20 
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In order to reduce the aggregates for an accurate molecular mass detection, the samples 
were dissolved in water at a final concentration of 1mg/ml and filtered twice by a using 
0.2 µm and 0.1 µm filters. The weight-average and number-average molecular masses of 
the Ulvan fractions obtained from absolute LS measurements were compared with the 
molar masses obtained by direct-standard-calibration relative to a well-characterized 
pullulan standard. This standard consist of α-(1,4)-D-glucopyranose units, with every 
third 1,4-linkage replaced by a 1,6-linkage, its equivalent units represent a reference value 
for the detection of  hydrodynamic weight for each sample of Ulvan. The hydrodynamic 
weight refers to the distribution of the polymer in solution, for this reason obtainable 
results correspond in an overestimation of molecular mass. The use of Pullulan 
equivalents as reference for molecular weight detection of the different batches of Ulvan, 
led to the obtainment of values three times higher in respect to those determined without 
any reference. 
As reported by theliterature is probe that the differential refractive index dn/dc is a critical 
constant for light scattering detection because is strongly influences the recorder 
molecular mass. The constant depends on sample, solvent, temperature and wavelength. 
Dn/dc should be determined by injecting a number of known concentrations of the sample 
in a calibrated RI detector [Berggren 2003]. Unfortunately the dn/dc value of Ulvan 
dissolved in the mobile phase containing 0.01% NaNO3 and 0.01% NaN3, remain 
unknown. For this reason a dn/dc value equal to 0.127 mL/g, found for carrageenan, was 
used as reference for the detection of Ulvan Mw. [Paradossi 2002]. The results displayed 
in Table 4.5 and Figure 4.6 showed a well defined molecular weight. Results were 
normalized using pullulan standard P20 and although aggregates in the range of 10 nm 








Figure 4.3 - Size exclusion chromatograms showing molecular mass distribution of samples 
dissolved in water (1mg/ml) and filtered 2 times using filter of 0.2 and 0.1µm: A) Ulvan I; B) 
Ulvan II; C) Ulvan U.P.; D) Ulvan N.P. 
 
Table 4.5 -  Molecular  weight  (Mw) and number-average (Mn) calculated by using dn/dc= 
0.127 mL/g. 
Sample Identity  Mw(Da) Mn  Mw/Mn  
 Ulvan I  46820  36080    1.30 
  Ulvan II  51240  48350    1.06 
  Ulvan U.P.  73400  61240    1.19 
 Ulvan N.P.  60080  39000    1.54 
 
 
4.1.5. Surface Analysis 
Electron Spectrometry for Chemical Analysis (ESCA) is the most widely used surface 
analysis technique because of its relative simplicity in use and data interpretation. The 
information ESCA provides about surface layers or thin film structures is of value in 
many industrial applications including: polymer surface modification, catalysis, 
corrosion, adhesion, semiconductor and dielectric materials, electronics packaging, 
magnetic media, and thin film coatings used in a number of industries [Garbassi 1998] 
For the analysis, the sample is irradiated with mono-energetic x-rays causing 
B
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photoelectrons to be emitted from the sample surface. An electron energy analyzer 
determines the binding energy of the photoelectrons  
 
Figure 4.4 - ESCA photoemission process. 
 
From the binding energy and intensity of a photoelectron peak, the elemental identity, 
chemical state, and quality of an element are determined. All elements, except hydrogen 
and helium can be detected. The sample placed in an ultrahigh vacuum environment and 
exposed to a low-energy, monochromatic X-ray source excitation causes the emission of 
photoelectrons from the atomic shells of the elements present on the surface. The energy 
of these electrons is characteristic of the element from which they are emitted. By 
counting the number of electrons as a function of energy, a spectrum representative of the 
surface composition is obtained. The area under peaks in the high resolution spectrum is a 
measure of the relative amount for each element present, and the shape and position of the 
peaks reflect the chemical state for each element [Chaney 1987] 
In order to obtain information about the chemical composition and structure of the Ulvan 
surface, each sample was investigated by means of Quantum 2000 scanning ESCA 
microprobe from Physical Electronics. The results revealed the detailed composition of 
their surface. The detected ions were prevalently N, S, Ca and further C and O. Cl and Si 
were also present likely as contaminants. The first data obtained, performed in order to 
have a comparative results for each batches, showed similar composition for 3 of 4 
RESULTS & DISCUSSION 
 75 
samples (Figure 4.5). It was interesting to notice in ultra purified batch the complete 
absence for nitrogen and sodium ions, compared to the other samples (Table 4.6).  
                     
A B 
C D 
Figure 4.5 - Binding Energy of Ulvan samples: A) UlvanI (flakes);B)Ulvan II (powder); C) Ulvan 
U.P. (Lamine);D) Ulvan N.P.(powder.).  
 
Table 4.6: Atomic Concentration Table %, raw samples. 
Sample Identity C1s N1s O1s Na1s S2p Cl2p Si2p  
  Ulvan I 58.30 6.90 28.71 4.21 1.08 0.79 --- 
  Ulvan II 58.60 4.11 32.03 3.48 1.77 --- --- 
  Ulvan U.P. 78.90 --- 18.03 --- 0.60 --- 2.47 
Ulvan N.P. 53.36 1.84 37.57 4.95 2.27 --- --- 
 
In order to obtain more detailed information about ultra purified batch, detailed ESCA 
investigations were performed. The analyses were carried out by comparing the untreated 
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sample with the same sample extracted with acetone. The obtained data showed that the 
impurities, such as silicon, were removed when the sample was washed with acetone. It 
was also possible to observe a clear increment of sulphate and Na when comparing the 
washed sample to untreated Ulvan. The high amount of sodium, also corresponding in O-
C=O or C4 peak (Figure 6) in high resolution spectrum, highlights a high content of 
uronic residues (Glucuronic or Iduronic acid) in the main backbone. The higher C2 peak 
in the washed sample, corresponding to C-O but also C-N bonds, confirms the presence 
of protein on the surface. After surface purification the increase of C3 peak, namely O-C-
O, C=O and also C-S bonds, could come from both sulphate groups present in the main 
chains and also from the proteins detected. All results obtained comparing raw samples 
and acetone extracted displayed and increase of protein and uronic contents on the surface 
samples after washing (Table 4.7). 
A B 
C D 
Figure 4.6 - Binding Energy of A)Ulvan I; B)Ulvan II; C)Ulvan U.P.; D)Ulvan N.P. 
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Table 4.7 - Atomic Concentration Table %, Acetone extracted samples. 
Sample Identity C1s N1s O1s Na1s S2p Cl2p Si2p  
Ulvan I 57.48 7.68 28.96 4.10 1.18 0.38 --- 
Ulvan II 53.69 4.48 35.22 4.47 2.15 --- --- 
Ulvan U.P. 63.39 0.91 30.32 2.78 2.31 --- 0.30 
Ulvan N.P. 53.03 4.07 36.66 3.95 2.29 --- --- 
 
 
Figure 4.7 - Binding Energy: Ulvan dissolved in water. 
 
 
4.1.6. Thermal Analysis  
The thermal properties of Ulvan were investigated by means of Thermo Gravimetric 
Analysis (TGA) and Differential Scanning Calorimetry (DSC).  
From TGA traces, performed both in air and nitrogen atmosphere, the Ulvans water 
content was estimated in around 10 wt%. On the other hand, the first decomposition step 
started at around 200°C, indicating that the thermal stability of the samples is greatly 
higher than their temperature of utilization (37°C). These observations were also 
confirmed by DSC analysis. In addition, the residual weight of the Ulvans calculated at 
600°C after contribution in air atmosphere was estimated in around 26%. As indicated by 
Carrasco 2004, this relatively high value can be probably attributed to both alga’s mineral 
substance and the sand and mineral compounds present in its natural habit. 
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4.1.7. Solubility of Ulvan  
Solubility represents an important parameter providing a relevant prediction of polymers 
properties and/or their interaction with different materials. It is useful in ensuring the 
suitability of polymers for practical applications and in formulating blends of solvents for 
particular purposes. For all these reasons, solubility of Ulvan was tested using different 
chemical solvents such as in N,N-Dimethylformamide (DMF), 1-4-Dioxane, 
Polydimethylsiloxane silanol terminated and trifluoracetic acid (TFA) at a concentration 
of 10 mg/ml. The investigations were carried out at room temperature (RT) and by 
heating up the sample. Results showed the non - solubility of Ulvan samples in every 
chemical solvent used but also a fast solubility in deionized water at room temperature. 
After complete dissolution the polymer solution appeared homogeneous. 
 
4.1.8. Infrared Analysis 
Since infrared spectroscopy (IR) represent a powerful qualitative and quantitative tool, 
useful in identifying chemical species and functional groups in a variety of complex 
samples, IR analysis was performed on Ulvan II powder in KBr pellet and analyzed by 
using a Jasco FT-IR 410 spectrophotometer. The main goal of the IR study was aimed at 
identify the fundamental groups in Ulvan structure to compare with the information 
obtained by using different type of analyses. The infrared absorption spectrum of 
polysaccharides from Ulva armoricana is showed in Figure 4.8. The signal around 1255 
cm
-1 
and two shoulder bands at 842 and 787 cm
-1 
were indicative of the presence of ester 
substitutions. Absorbance at 1255 cm
-1
 is attributed to stretching of C-O-S. Two other 
important bands were assigned at 1624 and 1056 cm
-1
 corresponding respectively to the 
stretching of C=O of uronic acid and the vibration of the C-O-C bridge of glucosides. 
Results gained were in according with data reported by Pengzhan et al, 2002.  
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Figure 4.8 - FT-IR of Ulvan II polymer. 
 
 
4.1.9. Viscosity Mesurements 
The conformational properties of polymer chain are usually determined in dilute solution 
of the polymers. Intrinsic viscosity (η) of polymer solutions is a measure of the volume 
associated with a given mass of polymer in dilute, undisturbed solution at thermodynamic 
equilibrium [Rushing 2004]. In order to obtain information of viscosity of investigated 
batches of Ulvan, samples were dissolved in deionized water, used as blank, at RT. 
Measurements were carried out at 25°C by using a Viscodoser AVS20 (SCHOTT) 
viscometer.  Intrinsic viscosity [η] values were determined by extrapolating value of the 
specific viscosity/concentration ratio at zero concentration (ηsp/c for c → 0). The obtained 
results revealed an intrinsic viscosity value in the range of 80 and 160 g/cm
3 
for the 
investigated batches.  
 
4.1.10. Glucuronic And Iduronic Acid Detection 
For a more accurate investigation, nuclear magnetic resonance (NMR) analysis was 
employed in order to try to determine the relative proportion of D-glucuronic acid and L-
iduronic acid present in Ulvan structure. The NMR spectra were recorded at 25°C on a 
Bruker DRX-400 spectrometer operating at 400 MHz for proton observation. All Ulvan 
samples (ca 10 mg ) were dissolved in 0.5 ml D2O and transferred in a 5 mm NRM tube. 
Acetone was used as internal reference. The achieved data revealed that the glucuronic 
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and iduronic acid signals were weakly revealed but appeared disturbed and not distinctly 
evident, because of the superimposition of the chemical shift of water. In order obtain 
clearer spectrum, further experiments were performed by increasing the temperature from 
25°C to 80°C. The recorder signal appeared not distinct as previously described. 
 
4.1.11. Cytotoxicity Tests 
The fundamental feature of biomaterials is their capability of interacting with organic 
tissues and biological fluids without eliciting secondary alterations or damaging processes 
of the living organism in which they perform their functions [Langer 1990, Hoecker 
1998]. In order to be considered suitable for biomedical applications, new materials must 
undergo a series of in vitro and in vivo tests to assess their biocompatibility. In particular, 
in vitro cytotoxicity tests have been standardised, they are rapid, not expensive and 
represent the first step in the evaluation of biocompatibility. Generally, for in vitro assays 
the presence of bio-toxic compounds is investigated by evaluating either cell morphology 
or the activity of specific cell enzymes. The high sensitivity of these analysis is 
guaranteed by restricted cell culture conditions and by the absorbance of the protective 
mechanisms that support cell in vitro [ISO 10993]. 
Both Ulvan I and Ulvan II were submitted to biological investigation for the in vitro 
evaluation of cytotoxycity. Based on international ISO 10993 guidelines, regarding the 
biocompatibility evaluation of materials for biomedical applications, the evaluation of 
cytotoxicity in vitro was performed on balb/3T3 clone A31 (ATCC CCL163) murine 
embryo fibroblast cell line. 
Experiments were performed by incubation of the cells with solutions of the materials in 
complete growth medium at different concentrations (1–10 mg/mL). After 24 hours, 
cultures were tested for cell proliferation by using Neutral Red Uptake assays. 
The Neutral Red test is a colorimetric assay for the quantitative determination of cell 
proliferation and viability based on the uptake of the vital dye by viable cells. Indeed, 
only these cells can uptake the dye by active transport and incorporate it into lysosomes 
by endocytosis, whereas non–viable cells cannot. After 2 hours incubation with Neutral 
Red, the growth medium was removed and cells were accurately washed with phosphate 
buffer saline (PBS2) to remove excess dye. The incorporated Neutral Red was then 
released from the cells in acidified ethanol solution. The number of vital cells in the 
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culture corresponded to the amount of uptaken dye, as determined by measurement of 
absorbance at 540 nm. 
Quantitative and qualitative results showed a good cytocompatibility of the investigated 
ulvan samples also at high concentration such as 10 mg/ml (Figure 4.9). The 
morphological investigation performed by optical microscopy confirmed the quatitative 
results, showing the good morphology of cells incubated with ulvan in respect to the 
control (Figure 4.10). The obtained results indicate the suitability of both type of Ulvan (I 
and II) for biomedical applications. 
 
Figure 4.9 - Neutral Red assay, cytotoxicity evaluation of Ulvan II. 
 
A B 
Figure 4.10 - Optical micrographics of mouse embryo fibroblast cell line balb3T3 clone A31. A) 
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4.2. POLYSACCHARIDES BASED SCAFFOLDS IN TISSUE ENGINEERING 
 Polysaccharides form a class of materials which have generally been underutilized in the 
biomaterials field. Recognition of the potential utility of this class of materials is however 
in growing and the field of polysaccharide biomaterials is poised to experience rapid 
growth [Suh 2000]. Three factors have specifically contributed to this growing 
recognition of polysaccharide potential. The first is the long-standing recognition that the 
oligosaccharide components of most glycoproteins are essential for normal function of 
these molecules. This has been coupled with a large and growing body of information 
pointing to the critical role of saccharides moieties in numerous cell-signaling schemes 
and in the area of immune modulation in particular. The second factor has been the 
realization that so called extracellular matrix (EMC) polysaccharides play critical roles in 
modulation the activities of signalling molecules as well as mediating certain intracellular 
signal directly. The third factor is the tissue engineering research and the associate need 
for new materials with specific, controllable biological activity, and biodegradability. In 
general polysaccharides share a number of features that make them, as a class, 
particularly desirable starting materials for biomedical applications. The numerous 
hydroxyl groups present on the typical molecule provide numerous sites for the 
attachment of side group. Such side group can provide specific functionality and 
biological recognition features, or may serve simply to modulate mechanical and 
biological properties of parent molecule [Ehrenfreund-Kleinman 2006]. Apart from their 
biological activity, one of the more important properties of polysaccharide is their 
hydrophilic nature, which allow them to be processed as hydrogels of various densities. 
Hydrogels can occur by a number of mechanisms and is strongly influenced by the types 
of monosaccharide involved. The ability to retain a significant amount of water, make 
polysaccharide-hydrogel quite similar to natural living tissue, rending them useful for a 
wide variety of biomedical applications [Hoffman 2002].  Several polysaccharide have 
been studied and proposed for scaffolds such as hyaluronic acid, collagen, alginate, 
chitosan, carrageenan and much other. In the present work the attention has been focused 
on Alginate, and in particular on the possibility to employ a new type of alginic material 
obtained from renewable resource such as green algae and known as Ulvan. Alginate is 
well know polysaccharide widely used due to it gelling properties in aqueous solutions 
related to the interactions between the carboxylic acid moieties and bivalent counter ions, 
such as calcium. The kinetic of gel formation is usually very fast and the resulting gels are 
strong enough to be suitable for scaffold preparation  
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4.2.1. Physically Crosslinked Alginate Based Scaffolds  
In virtue of the aqueous environment used in the methods of preparation and for their 
hydrophilic character and ability to sustain cell growth, alginate matrices have been 
attractive and widely investigated for many biotechnological and medical applications. 
This interest in alginates is also due to their high biocompatibility and low toxicity, and to 
the relative ease with which they can undergo gelation once in combination with divalent 
cations to form a three-dimensional network usually described as“egg-box”model (Figure 
4.11).  
 
Figure 4.11 - Eggs box model. 
 
Porous calcium-alginate scaffolds of more than 90% porosity 5 mm thickness and 2 cm of 
diameter were prepared exploiting the ionic interaction between the carboxylic groups of 
alginate and calcium ions in water solution. The highly porous three-dimensional 
structure was gained using the simple procedure of freezing the crosslinked hydrogel and 
subsequently lyophilizing the frozen hydrogel. The freezing and lyophilization technique 
created open-pore microstructures with a high degree of interconnectivity [Chung 2002]. 
In addition to the material properties, the morphology and microstructure of 3-D scaffold 
are crucially important as they may determinate the nature of the engineered tissue 
[Glicklis 2000]. Swelling behaviour and structural stability of scaffolds are also critical 
for their practical use in tissue engineering. Most natural polymers swell readily in 
biological fluids. In vitro culture studies indicated that initial swelling is desirable and the 
resultant increase in pore size facilitates cell attachment and growth in the three-
dimensional fashion. However, continuous swelling would lead to loss of mechanical 
integrity and production of compressive stress to surrounding tissue [Kuo 2001].  
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4.2.1.1. Alginate based hydrogels characterizations 
Preliminary test were performed in order to assess the swelling degree and the consequent 
dissolution time of the prepared constructs. Moreover the ultrastructure, essential 
requirements to ensure a biological environment conducive to cell attachment and 
proliferation [Li 2005], was investigated. Data obtained indicated that the three-
dimensional structure of the prepared scaffolds, in terms of pore size and evaluated by 
mean of SEM, resulted favourable for cell attachment. The highly porous structure 
showed pores of about 100 µm diameter, according to SEM measurement (Figure 4.12) 




Figure 4.12 -  Alginate scaffold A)dry; B)SEM image. 
. 
Swelling behaviour and structural stability were assessed by placing the dry scaffold in a 
6 wells culture plate and covered with an excess of cell growth media. The degree of 
swelling determined through this investigation was calculated by applying conventional 
swelling formula described in § 3.7. The measurements were performed both room 
temperature (RT) and at 37°C. The alginate scaffolds due to their hydrophilicity were 
easily wetted by the cell culture media (Figure 4.13). As showed in Figure 4.14A, the 
equilibrium was reached after 15 minutes and a fast up take of medium allowed for a 
maximum swelling with value in the range of 2400%. 
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Figure 4.13 - Swollen alginate scaffold. 
 
The hydrated alginate scaffold, transparent and with a soft consistence, showed a 
progressive and linear dissolution kinetic after 45 minutes. The weakening of the strength 
of interaction with time due to leaking of Ca
2+
 ions as a consequence of multiple media 
switches during the lifetime of the culture [Simpson 2004], led to the scaffold dissolution 
and loss the complete structural stability in 4 days at room temperature. Similar 
dissolution kinetic was observed in monitored scaffold at 37°C, as showed in Figure 
4.14B. In the present work, alginate was used for scaffolds preparation as reference 
material in respect to Ulvan. 
A 
B 
Figure 4.14 - Swelling degree of Alginate scaffols A)RT and B)37°C. 
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4.2.1.2. Alginate based scaffolds as support for cell adhesion and proliferation 
As widely reported in literature alginate based scaffolds are exploited, since long time, as 
suitable material for the preparation of hydrogels able to sustain a significant cell 
adhesion and proliferation. In the present study the goal was to evaluate the suitability of 
the prepared three-dimensional alginate constructs to sustain the adhesion and 
proliferation of HepG2, a human hepatocarcinoma cell line.. For this purpose a cell 
suspension, at a density of 1x10
6
cell/ml, was dropped onto the top of alginate scaffold 
previously sterilized under UV for 30 minutes. The hydrophylicity of the alginate material 
allowed the rapid wetting of the scaffold and entry of the liquid into the dry  sample. 
Because of the large pore diameter the liquid is able to flow in the torturous pore pathway 
allowing for the transport of cell and nutrient in the inner of scaffold. Despite the soft 
consistence once incubated in cell growth media, scaffolds were sufficiently stable to 
permit entrapment of the cells and the relative transparency allowed for the observation of 
seeded cells using an inverted microscope. Microscopical investigations showed that cells 
appeared dispersed immediately after seeding and tend to arrange in small viable 
aggregates after 24 hours. Larger spheroid structure, of few cells, is visible in the culture 
from the second day after seeding reaching an average size of more than 100 µm. The 
viability of multicellular aggregate was qualitatively evaluated by means of neutral red 
assay. The active up-take of vital dye revealed a high viability for more than 7 days. 
Spheroids morphology and size was also evaluated microscopically after treatment in 
paraformaldehyde overnight at 4°C and subsequent staining of nucleus and cytoplasm 
with toluidine blue (Figure 4.15). 
 
 
Figure 4.15 - Spheroids of HepG2 in alginate scaffold. 
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Observations of well defined spheroids, revealed that their size distribution formed within 
alginate mesh was maintained constant and relatively narrow, approaching that of the 
scaffold pore size (100 µm in diameter). It appears that the pore size of scaffold can 
dictate the size of formed spheroids [Glicklis 2000, Ranucci 2000]. The size of spheroids 
also appeared optimal for oxygen and nutrients flow and also for the maintenance of 
viability of aggregates during the culture time . 
 
4.2.3. Physically Crosslinked Ulvan based scaffolds  
In the last decade a new alginic material derived from renewable source, such as green 
algae (Ulva armoricana), was exploited for the extraction of gelling polysaccharide, 
namely Ulvan, a promising material for scaffolds preparation. The growing need of new 
bioactive materials and easy availability of this source led the scientists to investigate its 
peculiarity and potentiality as suitable candidate for regenerative medicine applications to 
use in substitution to commercial alginate.  
 
4.2.3.1. Ulvan gelation 
Preliminary trials were devoted to set up an appropriate technique for scaffolds 
preparation. For the obtainment of these constructs, boric acid was used in combination 
with calcium chloride for ulvan gelation, as specific crosslinking agent for this 
polysaccharide. The presence of boric acid give rise to a weak gel due first to the 
formation of boric acid ester, between H3BO3 and hydroxylic groups of Ulvan backbone 
and subsequently to ionic interactions between borate, with negative charge formed, and 
calcium cations. The chelation of calcium allows for the obtainment of complexes, more 
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Scheme 4.1 - Schematic representation of Ulvan crosslinked with H3BO3 and CaCl2. 
 
Furthemore the presence of acidic moieties on ulvan enables other interactions, such as 
ionic bridges between the carboxylic group of uronic acid and/or sulphate with borate 
through divalent cations, contributing also to the gel formation, how showed in the 
scheme 4.2 [Lahaye 1993] 
                       
 
Scheme 4.2: Alternative crosslinking process  between Ulvan and  H3BO3 & CaCl2. 
 
 
4.2.3.2. Physically crosslinked Ulvan based scaffolds characterization 
The scaffolds obtained using two different types of Ulvan ( I and II) and crosslinked by 
means of calcium chloride and boric acid were characterized for their three-dimensional 
structure and swelling degree. The ultrastucture investigated by SEM showed a highly 
interconnected porous structure with pores of 100µm structure for both types of ulvan, as 
observed for reference alginate based scaffolds (Figure 4.16). 
 




Figure 4.16 - Dry Ulvan based scaffold and SEM image of A) Ulvan I; B) Ulvan II. 
 
The swelling degree evaluated at RT and 37°C in an excess of cell growth media showed 




                  Figure 4.17 - Swelling Degree of scaffolds based on: A) Ulvan I; B) Ulvan II. 
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4.2.3.3. Biological characterization of physically crosslinked Ulvan based scaffolds 
As performed with the alginate based scaffolds, the prepared physically cross-linked 
ulvan based constructs were investigated for their ability to sustain HepG2 cell adhesion 
and proliferation.  
Cytocompatibility of the prepared construct was evaluated by seeding 1 milion of cells on 
the surface of scaffolds, as previously described. Optical microscopy investigation was 
used to evaluate the morphology of seeded cells on the novel three-dimensional natural 
polymer scaffold . Cells were fixed with paraformaldehyde and stained with tolidine blue. 
Results showed that viable cells tend to aggregate in lager number when cultured onto 
scaffolds but can not achieve an optimal spheroid shape comparable to that observed in 
commercial alginates based constructs. The scaffolds indeed, after 2 days in physiological 
condition appeared almost completely dissolved displaying their unsuitability to sustain 
the multicellular aggregation formation typical of this cell line. (Figure 4.18) 
 
 A   B 
Figure 4.18-  Ulvan II based scaffolds physically crosslinked with H3BO3 and CaCl2. a) HepG2 
seeded onto scaffolds b)cells aggregates in irregular clustes. 
 
4.2.3.4. Alternative physical crosslinking approach  
Further investigation, aimed at the obtainment of ulvan scaffolds resistant to dissolution, 
focused on the emploument of a new physical crosslinking agent during in scaffolds 
preparation, namely Dimethyl 3-3 dithio-propionimidate dihydro chloride (DTBP) 
(Figure 4.19). The introduction of DTBP allows the exploiting of electrostatic interaction 
between the positive charges of aminic groups present on crosslinker and the negative 




) and sulphate (SO4
=
) present in Ulvan 
structure. The electrostatic interaction between different charges determines the gelling 
formation. Ulvan II and Ulvan U.P. were used for scaffold preparation and DTBP was 
used alone as crosslinker or in combination with H3BO3.  
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Figure 4.19 - Dimethyl 3-3 dithio-propionimidate dihydro chloride(DTBP). 
 
The use of DTBP as physical crosslinking agent in Ulvan II based hydrogels preparation, 
gave rise to scaffolds which  displayed  a swelling degree in the range of 4000% both RT 
and 37°C. Cytocompatibility test were performed by seeding HepG2 on the top of 
prepared dry systems. The obtained data indicated that cells were able to form small 
aggregates after 24h but unable to maintain their shape because again scaffolds tend to 
dissolve in 2 days. . Anyhow viable cells were found attached onto the polystirene plastic 
surface of the culture well in the presence of the dissolved ulvan scaffolds (Figure 4.20). 
The obtained results highlighted on one side the inability of prepared construct to  
maintain their physical integrity in physiological conditions but also the non-toxic nature 
of both ulvan and of the new crosslinker used. Similar results were obtained when H3BO3 
was used in combination with DTBP in scaffolds formulation. 
A B 
Figure 4.20 - A)DTBP scaffold dry b)cells grown in the presence of DTBP crosslined Ulvan 
based scaffolds and stained with Blue toluidine. 
 
4.2.4. Chemically Crosslinked Ulvan Based Scaffolds: Preparation and 
Characterization 
In order to obtain ulvan based scaffolds resistant to dissolution in acqueous environment, 
it was decided to introduce stable covalent cross-linking thus allowing for a greater 
control over the mechanical and swelling properties of the hydrogels. For the preparation 
of these chemically crosslinked hydrogels the chemical modification involved the 
hydroxylic groups (OH
-
)  of the main backbone of Ulvan and the terminal epoxy groups 
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of a crosslinking agent  such as poly(ethylene glycol) diglycidyl ether (PEGDE). An 
epoxide is a cyclic ether with only three ring atoms. This ring approximately is an 
equilateral triangle, its bond angles are about 60°, which makes it highly strained. The 
strained ring makes epoxides more reactive than other ethers, especially towards 
nucleophiles. The introduction of PEGDE allowed the opening of the epoxy ring thanks 
to the nucleophilic action of OH
-
 groups present in Ulvan structure. Their interaction 
determines the ring opening and the formation of etherlinkage allowing for the 
obtainment of gel (Scheme 4.3). 
           
 
                        PEGDE                                                            Ulvan Structure 
 
 
             
 
 
                  
Scheme 4.3: Schematic representation of crosslinking mechanism between PEGDE and Ulvan.  
 
Crosslinking strategy targeting the alcohol groups via PEGDE crosslinker was 
investigated for the preparation of Ulvan based hydrogel resistant to dissolution in 
physiological conditions. Both types of Ulvan II and U.P. were used for this purpose. The 
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crosslinker was added directly to solution of Ulvan in NaOH (0.1N) while vortexing. The 
strongly alkaline environment (pH 13) was necessary to gain the reaction between Ulvan 
and PEGDE. The amount of crosslinker added was based on the molar ratio of alcohol 
groups in Ulvan to epoxide groups in PEGDE with 100% of theoretical crosslinks, where 
100% of theorical crosslinking indicate that 2 moles of PEGDE were added per mole of 
Ulvan since there are two epoxides in PEGDE and four alcohol per unit of Ulvan. The 
mixture was then heated a 60°C for 45 minutes, in order to allow the pendant epoxide 
groups on crosslinking agent to react with other Ulvan chains during the evaporation 
process. Part of the mixture was neutralized with 70 µl of glacial acetic acid in order to 
decrease the pH due to the NaOH used during the scaffolds formulation.  All the obtained 
constructs after the freeze-drying technique, showed a regular shape and a spongy 
consistency in the dry state and were characterized for their ultrastructure and swelling 
degree. Comparative study between neutralized and not neutralized systems were 
performed. The morphology and microstructure of scaffolds were examined using a 
scanning electron microscopy. The porosity, as principal parameter for scaffold to ensure 
a suitable environment for cell attachment and proliferation and the passage of nutrient 
flow, was carefully investigated. Results showed porous structure both on the surface and 
inside scaffolds (Figure 4.21). with regular tortuosity represented by interconnected pores 
of about 100 µm in diameter. 
A B 
Figure 4.21 - SEM image of Ulvan chemically crosslinked A) longitudinal section B) horizontal 
section. 
 
One of the major challenges in the fabrication of porous scaffolds is trade-off between 
adequate material porosity and mechanical strength to provide suitable support for cell 
growth, for these reason the ability of prepared constructs to uptake medium, in terms of 
swelling degree, was investigated. Scaffolds, prepared as previously described, were 
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allowed to swell in culture media both room temperature and 37°C. The trend of their 
swelling degree, for not neutralized scaffolds,showed that the chemically cross-linked 
samples retain original shape for prolonged time.  
Evaluation of chemically crosslinked scaffolds swelling degree showed a swelling kinetic 
similar to one observed for the physically crosslinked scaffolds reaching the equilibrium, 
with values in the range of 3000%, after 15 minutes. Conversely, the covalent constructs 
showed a slow dissolution time and the maintenance of its properties for extended time 
(Figure 4.22).  
 
A B C 
Figure 4.22 - Chemically Ulvan II based scaffolds A) dry scaffold; B) after 24 h; C) after 20 days. 
 
Similar results, in terms of 3-D structure and swelling degree,  were obtained when Ulvan 
U.P. was used for scaffolds preparation.. These preliminary results appear promising and 
allows to consider this type of scaffolds as possible candidate matrices for long-term in 
vitro culturing of cells. On the contrary, scaffolds neutralized with glacial acetic acid 
during their formulation, showed an immediate dissolution when in contract with culture 
media.  
 
4.2.4.1. Surface investigation of chemically Ulvan based scaffolds 
Analysys by ESCA were carried out in order to have a detailed information on the 
chemical composition of the surface of chemically crosslinked Ulvan U.P. based 
scaffolds. This investigation was designed to determine the modification of surface when 
PEGDE is introduced in scaffolds formulation. For this investigation, scaffolds were first 
crumbled and then pressed for the obtainment of thin table that were investigated by 
means of of Quantum 2000 scanning ESCA microprobe from Physical Electronics. 
Results were compared with Ulvan U.P. based scaffold prepared by dissolving Ulvan in 
deionized water. The obtained data showed a significant increase of Na most likely 
depending of the alkali used in scaffold formulation. This result is also confirmed from 
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the spectrum (Figure 23) in which the peak C4 appears higher than the peak revealed in 
the sample dissolved in water. C1 (C-C bond) and C3 peaks decrease in chemically 
crosslinked scaffold meaning that C-C bonds could come both from the impurities but 
also proteins. The same happen for C3, C-S bonds, coming mainly from sugar; in fact the 
peak decreases during the crosslinking reaction in which the protein is strongly reduced. 
C2 peak increases drastically, reaching almost the double of the value revealed in 
chemically untreated sample, data confirm the stechiometry used for scaffold preparation 
(crosslinker: polymer molar ratio 2:1).  It was possible also to observe an increment of C4 
in spectrum for Ulvan crosslinked with PEGDE meaning that the formed bonds could be 
coming a little from glucuronic acid present in Ulvan structure but mostly from 
crosslinker that could react also with carboxyl groups contributing at the optimization of 
crosslinking process (Table 4.8). 
 
A B 




                           Table4. 8 - Atomic Concentration Table % of Ulvan U.P. Acetone extra. 
Sample Identity  C1s  N1s O1s Na1s S2p  
Dissolved in water  56.03  1.00 35.45 4.65 2.87 
PEGDE Crosslinked         45.41   --- 41.88 11.49 0.51 
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4.2.5. Biocompatibility Investigation of Chemically Crosslinked Ulvan Based   
Scaffolds 
Biocompatibility tests were carried out by seeding HepG2 cell line onto not neutralized 
covalently crosslinked scaffolds in order to evaluate their potential to support cell 
adhesion and growth and the possible toxicity of chemical crosslinker used in scaffolds 
formulation. The systems, placed in 6-wells culture plate in a dry state, were sterilized 
under UV for 30 minutes and then washed twice with warm EMEM in order to buffer 
their pH.  The medium was removed and the swollen scaffolds were dried for 30 minutes 
under laminar flow. A suspension of 1 ml, containing 1x10
6
 HepG2, was dropped onto 
the  top of the scaffolds,fresh medium was added and incubated at 37°C in humidified 5% 
CO2 . By mean of microscopical observations it was possible to note that scaffolds were 
capable of retaining HepG2 in culture and no significant leakage from devices was 
revealed during the culture-time. Thanks to the transparency of constructs it was also 
possible to observe that HepG2 remained rounded and singular when seeding The 
organized and directed internal pores of the scaffolds allow for controlled seeding of 
HepG2. After 24 hours of inoculation, the cells began to cluster and form small viable 
aggregates. More than 90% of the seeded cells participate of spheroid formation, while 
few cells which did not aggregate lost their viability. After 7 days in culture, formation of 
spheroids as aggregates that have assembled into tightly packed spherical structures with 
smooth boundaries was observed (Figure 4.24). A careful microscopical investigation 
also highlighted that the formed spheroids were homogeneously distribuited in the upper 
two-third of the scaffold, while a reduction in size at the bottom of the sample correlate 
with the decrease in the percent cell occupation in that region.  This may be explained by 
the gravity method of cell seeding which involves dropping the cell suspension on the top 
of the scaffold. It might be also that cell concentration per polysaccharide specimen is 
insufficient to fill the its entire volume [Glicklis 1999]Daily investigations showed also 
that the multicellular aggregates exhibited a morphology which was distinctly different 
from the initial cell clumps, in which cells were seen to be loosely connected and 
irregular shaped. The spheroids display a maximal average size of 100 µm, which is at the 
same order of magnitude of scaffolds average pore size.  
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 A    B 
Figure 4.24 - HepG2 spheroids: A) after 2 days; B) after 7 days. 
 
An important issue with spheroids of this size is that they may suffer nutrient transfer 
limitations. The results of neutral red assay for a qualitative evaluation of cell viability 
indicate that indeed cells in 100 µm spheroids formed within the Ulvan based scaffolds 
maintained high viability throughout the culture time.  
In vitro biological evaluation of chemically crosslinked Ulvan U.P. based scaffolds 
showed similar results. . Data obtained also highlighted the non toxic nature of crosslinker 
used and an excellent biocompatibility of scaffolds for HepG2 that were able to grow and 
maintain their morphology and viability for more than 1 month in culture.  Taken together 
these results suggest that chemically crosslinked Ulvan are suitable matrices for the long-
term in vitro culturing of cells.  
 
4.2.6 Chemically Crosslinked Ulvan/Xylan Based Scaffolds 
The availability in sugar constituents, glycosidic linkages and structure of glycosyl side 
chain as well as two reactive hydroxyl groups at the xylose repeating unit of the main 
chain of xylan offer various possibilities for region-selective chemical and enzymatic 
modifications. The opportunity to exploit the valuable properties of xylans in combination 
with Ulvan for scaffolds preparation was investigated. Two type pf xylans were tested for 
this purpose, an ultra purified batch extracted at Chalmers University Laboratories 
(Göteborg, Sweden) and a commercial available product. The xylan added to Ulvan 
(2%w/v) at a final concentration of 2% and 4% w/w respectively was dissolved  in NaOH 
pH 13. The polymeric mixture was then added of chemical crosslinking agent PEGDE , 
under vigorous stirring and before to place the tlate in oven at 60°C for 45 minutes. The 
scaffolds obtained by freeze-drying technique were investigated for their swelling degree 
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in an excess of cell groth media. The prepared constructs showed an unexpected 
propensity to a fairly fast dissolution. This behaviour has yet to be further investigated. 
 
 
4.3. ALGINATE BEADS FOR CELL ENCAPSULATION 
Entrapment of mammalian cells in physical membranes has been practiced since early 
1950s when it was originally introduced as basic research tool. Since then the method has 
been developed on the promise of its therapeutic usefulness in tissue transplantation. 
Encapsulation physically isolates a cell mass from an outside environment and aims to 
maintain normal cellular physiology within a desired permeability barrier. Cell 
encapsulation aims to entrap viable cells within the confines of semi-permeable 
membranes. These membranes are expected to be permeable for transport of molecules 
essential for cell survival, but not to allow the transport of molecules larger than a desired 
critical size. Despite its non-physiological nature, the permselective capsule environment 
has been showed to support cellular metabolism, proliferation, differentiation and cellular 
morphogenesis [Uludag 2000]. The primary impetus behind the recent development of 
cell encapsulation technologies has been the desire to transplant cells across the 
immunological barrier without the use of immunosuppressant drugs. The latter, due to 
their systemic administration, are associated with unwanted side effects due to non-
specific suppression of the immune system that leads to a variety of undesired 
complications (e.g., opportunistic infections, failure of tumor surveillance, as well as 
adverse effects on the encapsulated tissue) [Morris 1996, Weir 1999].  
By surrounding a transplant with a membrane barrier, the access for host’s immune 
system to the transplant can be physically prevented. Depending on the choice of 
membrane material and whether membranes are prefabricated or fabricated around viable 
cells, cell will be subjected to different entrapment conditions. Spherical gel beads 
containing living cells have been applied in the transplantation in treatment of hormone or 
protein deficient diseases [Alhendy 1996] and cancer therapy [Read 2001, Cirone 2003]. 
Another utilization include microcarriers [Kwon 2002], scaffolds [Wang 2003] for cell 
cultures and tissue engineering [Stevens 2004]. As gel materials, polyelectrolyte complex 
systems have often been used. Among them, calcium alginate is the most commonly 
employed system for its easiness in gel formation. Once liquid alginate solutions are 
contacted with polycation (Ca
2+
), they immediately transformed into gel by binding 
between guluronic acid blocks in alginate and Ca
2+ 
[Sagiura 2005]. Smaller beads offer 
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many advantages, such as better transportation of nutrients and oxygen [Chicheportiche 
1988], better dispersion, better mechanical strength, easier implantation, and potential 
access to new implantation sites [Leblond 1999]. 
 
4.3.1. Naked Alginate Beads 
The set up of alginate beads preparation procedure represented the first step for cell 
encapsulation. The alginate beads prepared by ionotropic gelation were first analyzed 
macroscopically in term of surface homogeneity and then characterized from a 
dimensional and morphological point of view by means of granulometry in suspension 
and scanning electron microscopy (SEM). The macroscopic observation displayed a 
spherical shape e smooth surface just after gelation. The dimensional analysis of 
microparticles were carried out by granulometry showed a diameter distribution of beads 




           
Figure4.23 - Morphology and Diameter distribution of alginate beads. 
                                         
 
The  surface microstructure of of dried beads was investigated using scanning electron 
microscopy. The SEM photomicrograph of the beads showed a relatively smooth surface.  
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Figure 4.24 - SEM image al alginate beads 
 
4.4. ALGINATE BEADS LOADED WITH HEPG2 
Due to their non toxic nature and biocompatibility alginate beads for cell encapsulation 
represent a potential attractive carrier intended for implantation. Hepatic tissue 
engineering within these beads can find clinical applications in replacing a damaged liver. 
Widely used preparation techniques for preparing alginate beads include ionotropic 
gelation. This technique suitable for many applications. is in growing use for cells 
encapsulation due to the capability of alginate to be processed under mild conditions. The 
ionotropic gelation technique is based on entrapment of individual cell in an alginate 
droplet that is transformed in a rigid beads by gelation in a divalent cation rich solution 
(mostly calcium, Ca
2+
) [Uludag 2000]. The excess amount of CaCl2 solution compared to 
alginate solution is expected to prevent coalescence between the alginate beads formed. 
Calcium alginate beads were formed by reaction between the alginate droplets and CaCl2 
droplets [Sugiura 2005]. Beads formed under sterile condition and without contamination, 
favour the success of living cells encapsulation. In general, calcium alginate beads have 
been utilized to encapsulate cells for hybrid artificial organs, [Hisano 1998, Goosen 
1985], as haemoglobin carriers, for macromolecules delivery [Hari 1996] and for oral 
drug delivery of growth factors.. The goal of this study was to utilize calcium alginate as 
a matrix to develop stable microspheres for HepG2cell encapsulation. For this purpose, 
polymer solution containing 1x10
6
 cell was dropped in calcium chloride solution (Figure 
4.25A) and immediately rinsed with war EMEM. Microscopical observation confirmed 
the presence of cells loaded in alginate beads, which displayed spherical shape, smooth 
surface, and similar diameter (Figure 4.25B) in respect to un-loaded beads (Figure 4.23). 
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  A   B 
Figure 4.25 - Alginate beads A) preparation B) beads in cell growth medium. 
 
Quantitative evaluation of encapsulated cell viability carried out by WST-1 cell 
proliferation reagent was performed at 3-, 7-, 9, 15, 21- and 29 days. Results revealed a 
maximal viability for HepG2 during the first week that was maintained high throughout 
30 days (Figure 4.26).  
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Figure 4.27 - Encapsulated HepG2 in aginate beads. 
 
Morphology of HepG2 loaded into beads was daily monitored by optical microscopy 
observation. During the first week of colture cells appeared to proliferate in cohesive 
colonies that after further 7 days of culture tend to spatially organize in clusters with a 
radial disposition in the beads. This structure was highlighted at day 29 of culture after 
treatment with the vital dye Neutral Red that is uptaken only by viable cells (Figure 4.27). 
During the 30 days culture it was possible to observe the partial disruption of some 
alginate beads starting from day 15. Anyhow the cells released from the beads maintained 




Figure 4.28 - Disrupted alginate beads and released HepG2 stained with neutral red. 
 
 
15 days 7 days 
21 days 29 days 
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5. CONCLUDING REMARKS 
 
The present PhD research project was aimed at the investigation of a new type of alginate, 
know as Ulvan, for the development of scaffolds and beads to be used in biomedical and 
tissue engineering applications. Ulvans derived from renewable resource such as Green 
algae (Ulva armoricana), were deeply investigated as new source of polysaccharide. Due 
to the large availability of the source and their non-toxic nature the potential of this new 
material was investigated as alternative to commercial alginate, that have been taken as 
reference material. The results so far achieved allow for drawing the following 
concluding remarks. 
 
 Ulvan Based Scaffolds Preparation.  
Ulvan based scaffolds were first prepared in a conventional way by using boric acid and 
calcium chloride as specific crosslinking agents for the extracted Ulvans. The obtained 
construct, compared to alginate scaffolds, showed a dissolution time that occurred in 2 
days under physiological conditions. Thus, in order to improve the physical and 
morphological coherent characteristics of the prepared constructs, physical and chemical 
crosslinking agents, namely dimethyl 3-3’-dithio propionimidate (DTBP) and 
poly(ethylene glycol) diglycidyl ether (PEGDE) respectively, were introduced in the 
scaffold formulations. The investigation of the swelling degree of the prepared systems 
displayed a slow dissolution for chemically crosslinked Ulvan based scaffolds in respect 
to the physically crosslinked. The covalently crosslinked scaffolds were then submitted to 
careful investigation for their three-dimensional structure and biocompatibility test by 
using HepG2 cell line. The results showed that the cells spontaneously formed spherical 
multicellular aggregates identified as spheroids, and were able to maintain the 
morphology and viability for more than 20 days. Similar results, in term of spheroids 
formation, were achieved when alginate scaffolds were used in combination with HepG2. 
 
 Cells Loaded Alginate Beads. 
 Alginate beads loaded with HepG2 were prepared and characterized. Quantitative 
evaluation of loaded cells viability carried out by mean of WST-1 tetrazolium salt assay 
showed that HepG2 loaded into alginate beads display a high proliferation throughout the 
30 days period of investigation. 
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 Chemical-physical Characterization of Ulvan . 
Constituents of Ulvan main backbone and molecular weight were careful investigated. 
The analyses performed on different Ulvan batches confirmed the heterogeneous structure 
of this polysaccharide consisting of uronic acid, sulphate groups, and rare sugar, such as 
rhamnose. The polysaccharides fraction also contained hight amounts of ash. Molecular 
weight investigation revealed a molar mass in the range of 40-70 kDa. 
 
 General Final Comment. 
In the present research work, the main goal of the planned activity regarding the 
preparation and the biological evaluation of scaffolds and micro/nanoparticle loaded with 
cells based on naturally derived material, was achieved. The acquired information on 
Ulvan composition have been particularly helpful to understand the biological and 
physico-chemical properties of this new alginate in order to properly exploit its potential 
as innovative material for biomedical applications and pharmaceutical. These results 
combined with data obtained from Ulvan based scaffolds preparation suggest the 
suitability of these construct to sustain hepatic cell proliferation and aggregation in viable 
speroids. Alginate beads were also successfully loaded with HepG2 showing high value 
of viability. Future investigations will be aimed at setting up an appropriate protocol for 
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